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Allergy affects the everyday life of many people. This is illustrated by
estimations that almost half the population of the western world is atopic for one
or more environmental ‘allergens’ and that 155 million individuals suffer from
asthma, an allergic disease, worldwide10,69,70,106.
The word ‘allergy’ for ‘deviation from the original state’ was introduced at the
beginning of the 20th century and originally described a variety of harmful
immune reactions to vaccination. To differentiate the familial syndrome of
asthma and hay fever from these mixed reactions the term ‘atopy’ for ‘strange
disease’ was usedi.
The earliest report describing clinical phenomena of an allergic response was
already written before 925 AD by Rhazes21. Since then, the foundations of
allergy have started to evolve slowly, with the description of the pathology of
‘catarrus aestivus’ or hay fever (1819), discovery of a causative link with pollen
grains (1873) and a transferable tissue sensitizing serum factor (1921), which
was later identified as IgE (1976)69. However, not before the last three decades
science has begun to understand the molecular basis of this immune deviation.
Allergic response
Allergy is the result of a humoral response of the immune system to an allergen,
an antigen that due to particular characteristics (reviewed by Corry et al.31) is
able to skew an immune reponse. Humoral immune responses can be divided
in two phases. During the first phase, recognition of the antigen by the immune
system leads to the production of antigen-specific antibodies. During the second
phase, activation of an effector mechanism results in elimination of the antigen.
Antibodies can be grouped into different classes, based on their Fc domain and
each class is recognized by a specific set of receptor isotypes, Fc receptors.
Because Fc receptor isotypes are differentially expressed in a cell type-specific
manner, the antibody class determines the effector cell type that is activated. In
other words, specific antigen recognition is linked to a particular effector
mechanism through the class of antibody involved.
Sensitization
Antigens that have entered the body are handled through two separate
pathways (figure 1). On one end, antigens are taken up by macrophages and
dendritic cells. These highly specialized cells are able to process antigens and
present their peptide fragments on the cell surface together with molecules
required for lymphocyte activation, and hence are called antigen-presenting
cells (APC)ii. Presented peptides are specifically recognized through the antigen
receptor on ‘helper’ T lymphocytes (TH cells). This APC-TH cell interaction
triggers activation of the latter cell and subsequent production of a specific TH
cytokine profile. On the other end, native antigens are bound by the antigen
receptor on B lymphocytes that is subsequently activated. Costimulation of this
B cell through physical interaction with the activated TH cell and TH cytokines,
promotes maturation into a plasma cell that produces and excretes antigen-
specific antibodies82.
                                                          
i During time, allergy has lost its original broad meaning and currently the terms atopy and
allergy are used interchangeably (see also Holgate69).
ii For abbreviations see page 101
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Activation of a TH cell by an allergen triggers the production of a so-called TH2
cytokine pattern. Of this cytokine subset predominantly interleukin (IL)-4 and
IL–13 are responsible for B cell maturation into a plasma cell that produces IgE
antibodies31. Formation of allergen-specific IgE is the key event in the
development of allergy. Through binding to a high-affinity Fc receptor (FcεRI),
IgE links the specific recognition of antigen to the mast cell effector
compartment. Binding of IgE to FcεRI on mast cells does not evoke a response
but primes these cells for subsequent encounter with the allergen and is hence
referred to as sensitization.
Effector phase
Mast cells play a major role during the effector phase of an allergic response.
Activation of sensitized mast cells by multivalent allergen triggers release of
inflammatory mediators from mast cell granules. These mediators, for example
histamine, cause constriction of the bronchial airways, vasodilation, vascular
permeability, mucus secretion and other responses that induce clinical
phenomena associated with allergy59. These cells were described in the 1870s
by Paul Ehrlich and termed ‘Mastzellen’, for ‘well-fed cells’, because of their
cytoplasm, stuffed with prominent granules42 (figure 2). Mast cells are found in
all tissues throughout the body, particularly associated with blood vessels and
nerves and in proximity to surfaces that interface the external environment,
such as skin, intestins and lungs105.
Figure 1. Schematic representation of an allergic response. During the sensitization phase,
1. allergen is taken up, processed and presented by an antigen-presenting cell (APC) to an
allergen-specific helper T lymphocyte (TH cell), and this cell is subsequently stimulated to
produce a TH2 cytokine pattern; 2. native allergen is specifically recognized by a B lymphocyte
(B cell), which are subsequently activated. Costimulation of the activated B cell with TH2
cytokines drives this cell through maturation into an IgE-producing plasma cell. Allergen-specific
IgE binds to a high-affinity Fc receptor (FcεRI), expressed on mast cells. Renewed encounter of
a sensitized mast cell with allergen triggers release of inflammatory mediators.
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FcεRI
The major receptor for mast cell activation leading to degranulation is
FcεRI88,107,161. Based on similarities in structural features and signaling targets,
FcεRI has been placed in the multichain immune recognition receptor (MIRR)
family together with the B and T cell antigen receptor and several IgG Fc
receptor isotypes (figure 3). The FcεRI multimeric complex consist of an α-
chain, which binds IgE, a β-chain, which plays a role in membrane stabilization
and serves as a signal amplifier, and two γ-chains, which form the connection
between the receptor complex and the intracellular signaling events leading to
degranulation. The β- and γ-subunits contain conserved immunoreceptor
FcεRI FcγRIII FcγRI TCR/CD3 BCR
Figure 3. ITAM-containing immunoreceptors. The tetrameric FcεRI is shown in the context of
other members of the MIRR family. Grey circles represent immunoglobulin domains. ITAM
motifs are shown as crosses. TCR, T-cell antigen receptor; BCR: B cell antigen receptor; Ig:
immunoglobulin; ITAM: immunoreceptor tyrosine-based activation motif. (Adapted from
Nature)161
Figure 2. The mast cell. Pulmonary mast cells visualized by electron microscopy. The electron
dense granules are clearly distinctive. A. unstimulated and B. partially degranulated due to
stimulation with allergen (courtesy of Dr. Frank A. Redegeld).
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tyrosine-based activation motifs (ITAMs). The tyrosine residues in the ITAM
consensus sequence (D/E-XX-YXXL-X7-11-YXXL-L/I) conserved among Fc
receptors, serve as phosphoacceptors through which the receptor subunits can
interact with downstream signaling proteins.
Stimulation of a sensitized mast cell through binding of multivalent antigen to
receptor-bound IgE induces clustering of FcεRI. This initiates a chain of
phosphate transfer events within the receptor environment (figure 4A). The first
events of the signaling cascade involve phosphorylation of the tyrosine residues
of the FcεRI-β and -γ ITAMs by protein tyrosine kinase (PTK) Lyn. Phospho-
ITAMs serve as docking sites for proteins that contain a Src-homology-2 (SH2)
domain. Subtle variations between FcεRI-β and -γ ITAMs result in affinity for
different SH2-containing proteins. Phosphorylation of FcεRI-β ITAM leads to the
recruitment of additional Lyn to the receptor complex and binding to the
phospho-ITAM enhances the enzymatic activity of this PTK. Phosphorylation of
the FcεRI-γ ITAM subsequently leads to the recruitment and activation of
cytosolic Syk, a PTK of the ZAP-70 PTK family. Activation of Syk has been
shown to be sufficient as well as obligatory for induction of mast cell
degranulation32,132.
A subsequent series of signaling events, involving activation of various adapter
molecules that will not be discussed here (reviewed in Turner et al.161), lead to
membrane recruitment of cytosolic phospholipase Cγ1. This enzyme catalyses
the formation inositol-1,4,5-trisphosphate (IP3) and diacylglycerol DAG from
membrane phospholipids (figure 4B). IP3 binds and opens the IP3 receptor
calcium channels on the surface of the intracellular calcium stores, which
triggers the release of calcium. To establish sustained elevation of the cytosolic
Ca2+ concentration, required for degranulation, an influx of calcium from the
surrounding environment is initiated by opening of ‘store-operated’ calcium
channels in the plasma membrane. Elevation of the cytosolic Ca2+
concentration leads to mast cell degranulation, and although a role for calcium-
binding calmodulin and calmodulin-dependent kinase have been
established25,168 the signaling events between calcium influx and exocytosis of
granular contents are not very well analyzed in mast cells.
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Figure 4. FcεRI activation induces complex networks of signaling events. A, Early events
in FcεRI signaling. FcεRI α-chains are aggregated by crosslinking of bound IgE by multivalent
antigen. Association of the receptor complex with activated Lyn induces phosphorylation of the
β- and γ-chain ITAMs (indicated by !), the latter is then able to recruit Syk, which is in turn
activated by Lyn. Subsequent actions of Lyn and Syk, include the activation of PI(3)Kinase to
produce PtdIns(3,4,5)P3 (PIP3) (not shown in this cartoon), phosphorylation of the Bruton’s
kinase (Btk) and phosphorylation of the membrane-localized adapter protein LAT. B, FcεRI
control of [Ca2+i]. Btk, which is localized at the membrane by binding to PIP3, contributes to
activation of PLCγ1, which in turn has been brought to the membrane by the phosphorylated
LAT adapter. PLCγ1 acts on membrane inositol phospholipids to generate Ins(1,4,5)P3 (IP3) and
DAG. The intracellular targets of the latter include PKC isoforms, whereas IP3 binds to the IP3
receptors (IP3R) on the surface of the endoplasmic reticulum (ER) calcium stores, leading to
store depletion and elevation of cytoplasmic calcium levels. Depletion of ER calcium stores is
coupled to opening of plasma membrane channels for calcium influx; the calcium release
activated current (ICRAC) is mediated by these store-operated calcium channels (SOCC), and is
responsible for sustained elevations in cytosolic calcium and refilling of ER stores. (Adapted
from Nature)161
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Factors associated with development of allergy
The mere fact that mast cells exist suggests that, although they can cause
serious damage, their presence has provided an evolutionary benefit. Indeed, a
physiological role for mast cells in various processes such as wound healing,
angiogenesis, host defense against parasites, and innate immunity has been
reported1,6,51,52. During the last century the incidence of atopy has increased
rapidly to epidemic proportions. This strongly suggests that external factors play
an important role in the development of allergic diseases, causing mast cells to
do harm instead of good.
Epidemiology studies indicate that atopic disorders have their origin in
childhood and are associated with lifestyle30. For example, hygiene in the
Western society has been indicated as an important factor83. Besides
environmental factors, the development of asthma appears to have a genetic
basis30. Most of these factors are explanatory for the skewing towards IgE
production during a humoral immune response. However they can not explain
the observation that many people who are atopic by skin tests, do not have
symptoms of an allergic disease. Furthermore, there is no explanation for the
observation that equivalent levels of hypersensitivity to the same allergens in
different subjects results in skin disease (atopic dermatitis) in some subjects, in
nasal inflammation (rhinitis) in others, and a multi-organ disease in still another
population70. Overall, these observations suggest that in the target organ the
function of a sensitized mast cell is modulated by factors, which are specific for
the local microenvironment.
Mast cells and their microenvironment
Mast cells do not form a homogeneous population and morphologic differences
between mast cells found at different anatomical locations can be observed50. In
the rodent system mast cells are classified into connective tissue-type (CTMC)i
and mucosal (MMC) mast cells. In addition to differences in morphological and
histochemical characteristics, rodent MMC and CTMC appear to differ in many
other aspects of natural history, biochemistry and function (table 1)4,17,105,108,172.
Regulatory effects of various microenvironmental components on mast cell
function have been demonstrated. For example, cytokines such as IL-340,
soluble stem cell factor29,85,151,156, interaction with fibroblasts via membrane-bound
stem cell factor121 and neuronal cells18,154, and integrin-mediated cellular
adhesion to extracellular matrix-components fibronectin and laminin enhance
degranulation62,64,131,167,177. The number of factors reported to affect the functional
repertoire of mast cells in vitro increases rapidly, and at least some of these
factors may prove to play an important role in the modulation of mast cell
activity in vivo.
In all tissues throughout the body, resident mast cells are surrounded by
extracellular matrix-components. Very late antigen-5 (VLA-5) has been
identified as a key receptor for adhesion of mast cells to fibronectin45,87,175,177. The
observation that VLA-5-blocking antibodies strongly suppress passive
                                                          
i For abbreviations see page 101
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Connective tissue-type
mast cell (CTMC)
Mucosal mast cell
(MMC)
Size 10-20 µm 5-10 µm
Formaldehyde fixation Resistent Sensitive
Staining Safranin Alcian blue
T-cell dependence in
development
No Yes
Protease content MMCP-3, -4, -5, -6, -7 MMCP-1, -2
Proteoglycans/
Molecular mass
Heparin/
750-1000 kDa
Chondroitin sulfate di B/
100-150 kDa
Histamine 10-20 pg/cell 1 pg/cell
Serotinine 1-2 pg/cell < 0.5 pg/cell
Prostaglandin D2 + +
Leukotriene C4 - ++
Activated by
   FcεRI aggregation
   Compound 48/80
   Substance P
Yes
Yes
Yes
Yes
No
No
Inhibited by sodium
cromoglycate
Yes No
β-subunit
isoform
α-subunit
isoform
ligand
1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8
V
1
m
x
IIb
v
6
v
v
4
IEL
v
collagens, laminin
collagens, laminin
fibronectin, laminin, collagens
fibronectin (V25), VCAM-1
fibronectin
laminin
laminin
?
vitronectin, fibronectin
ICAM-1, ICAM-2
C3b (complement), fibrinogen, ICAM-1
fibrinogen, C3b
fibrinogen, fibronectin, von Willebrand F.
vitronectin, von Willebrand F., fibronectin,
thrombospondin, osteospondin, collagen
laminin?
laminin
fibronectin
fibronectin (V25)
?
?
Table 2. The integrin receptor family. (Adapted from Cell)76
Table 1. Rodent mast cell characteristics
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cutaneous anaphylaxis, indicates that this receptor is a potent modulator of
mast cell function131,177. The mechanism by which VLA-5 modulates mast cell
function is not completely clear, however could be of interest for the
development of future therapy against allergy.
Adhesion via VLA-5
VLA-5 is a member of the integrin family. Integrins are heterodimeric membrane
receptors that mediate cell-cell and cell-extracellular matrix interactions, and
play a role in various physiological processes139. Currently, eight β- and fourteen
α-chain isotypes have been identified. Dimerization of a particular α- and β-
chain results in affinity for a particular ligand (table 2). VLA-5 consists of an α5
and β1 chain and binds the arginin-glycin-aspartic acid (RGD) sequence in
fibronectin. On resting cells, integrins exist in a low-affinity conformation and, in
order to induce adhesion, a conformational change to a high-affinity state is
required. Various mediators such as interleukins79,141, chemokines99,171, and
growth factors such as stem cell factor13,36,167 have been shown to induce VLA-5-
mediated adhesion to fibronectin. The mechanism through which each of these
mediators modulate integrin affinity involves intracellular signaling events and is
hence referred to as ‘inside-out’ signaling (figure 1)44,46,55,74,93. In addition, divalent
cations Mn2+ and Mg2+ have been shown to directly induce a high-affinity state
of VLA-5, and this effect can be antagonized by Ca2+ ions116-118. The extracellular
domain of the VLA-5 α-chain contains several cation-binding motifs that are
highly homologous with the calcium-binding EF-hand motif of calmodulin160.
Binding of Mn2+ to α5 ‘EF-hand-like’ domains induces a conformational change
of the integrin, enabling fibronectin-binding. A calmodulin EF-hand loop is
formed by thirteen amino acids of which five play a role in coordinating the
binding of Ca2+ by means of their negatively charged side chain (figure 2A). In
α5 EF-hand-like motifs, the coordinating glutamic acid of the calmodulin EF-
hand is replaced by an uncharged, therefore nonfunctional, valine. It has been
postulated that in the EF-hand like domain located in the α5 ligand-binding
region, the coordinating function of glutamic acid is taken over by the negatively
inside-out
signaling
ligand
outside-in
signaling
low-affinity high-affinity
FAC
formation
α β
Figure 1. Integrin affinity modulation. Unstimulated integrin αβ-heterodimers exist in a low-
affinity conformation on the plasma membrane. Through inside-out signaling the conformation
of the receptor is converted to a high-affinity state, which enables ligand binding. Upon ligand
binding integrins are clustered, which initiates outside-in signaling and subsequent focal
adhesion complex (FAC) formation.
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charged side chain of aspartic acid of the RGD ligand sequence. In this view,
high-affinity binding is the result of change of integrin conformation, cooperative
coordination of Mn2+ by the integrin and the ligand and stabilization of this
complex by the cation itself (figure 2B)7.
Binding of VLA-5 to fibronectin and subsequent clustering of the integrins
triggers ‘outside-in’ signaling, involving tyrosine phosphorylation and influx of
calcium58. Subsequent recruitment of a range of proteins from the cytosol to the
cytoplasmic tails of the integrins leads to the formation of complex protein
A
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Figure 2. Mechanism for Mn2+-induced adhesion of VLA-5 to fibronectin. A. The amino
acid sequence of the calmodulin (CaM) EF-hand and cation-binding motif of VLA-5 α5 and
coordination amino acids (*) are shown. Due to a glutamic acid (Glu)-valine (Val) substitution
(←), the loop that forms the calcium-binding domain of VLA-5 α5 contains four cation-
coordination amino acids compared to five in the EF-hand loop of calmodulin. B. Due to Mn2+-
binding to cation-binding motifs in VLA-5 α5 this integrin is converted to a high-affinity
conformation. Mn2+-binding is cooperatively coordinated by four amino acids of a cation-binding
domain in the ligand-binding region of VLA-5 α5 and aspartic acid (Asp) of the arginin-glycin-
aspartic acid (RGD) sequence of fibronectin.
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structures, or focal adhesion complexes, at the cell-fibronectin interface. Focal
adhesion complexes have been indicated as hotspots of cellular signaling and
play a role in cytoskeleton reorganization of the cell22,33,100.
Formation of signaling complexes: SMAC and rafts
There are several possible mechanisms by which VLA-5 could modulate the
FcεRI signaling cascade. Increasing data suggests that many of the most
important cellular functions, such as signal transduction, are carried out by
modules made up of different species of interacting molecules3,68. In mast cells
these supramolecular activation complexes (SMACs) could be assembled from
VLA-5, FcεRI and focal adhesion complexes. Such supramolecular assemblies
could provide a local membrane environment for efficient signal transduction
and complex stability through attachment to the cytoskeleton components.
Increased stability and lifetime within a signaling aggregate enhances the
biological potency of an individual FcεRI according to the concept of ‘kinetic
proofreading’71,104,159, which postulates that a cascade of intracellular events
unfold as long as the initiating event is maintained.
Besides SMACs, so-called rafts have been shown to play an important role in
the initiation of the signal transduction cascade of MIRRs. These detergent-
resistant microdomains in the plasma membrane that are formed due to lateral
interaction of lipids and proteins and are enriched in sphingolipids, cholesterol,
glycosylphosphatidyl-linked glycoproteins and Src PTKs such as Lyn (figure
3A)66,81,146. They are distributed in a patchy manner over the plasma membrane
of various cell types. It was previously demonstrated that interaction between
antigen presenting cells and T cells, leads to membrane reorganization and
aggregation of antigen-specific T cell receptors (like FcεRI, a member of the
MIRR family) and costimulatory molecules with rafts77,166. Subsequent SMAC
assembly of local T cell receptor components and raft-associated intracellular
signaling molecules114, into a so-called ‘immunological synapse’, triggers T cell
activation61.
One step in the initiation of the early events of FcεRI signaling that remains
unclear, is the transition of Lyn from an inactive to an active state. Recent data
has suggested a possible role for rafts in this signaling step. Aggregation of
FcεRI by binding of multivalent allergen to receptor-bound IgE causes this
receptor to associate rapidly with rafts144. Subsequent association of FcεRI with
active Lyn would induce phosphorylation of the β- and γ-subunits and initiate the
FcεRI signal transduction cascade (figure 3B). Disruption of raft integrity by
cholesterol depletion78 impairs FcεRI signaling143 and furthermore blocking of
cholesterol biosynthesis in mast cells inhibits allergen-induced
degranulation37,142.
Recently, a role for rafts in integrin function was demonstrated89, possibly due to
their enrichment for Src-kinases that are important for focal adhesion complex
formation22,33. Interaction with integrins might therefore also influence the
association of rafts with FcεRI.
In summary, complex stabilization through formation of SMACs and enhanced
association with rafts could be the molecular basis for VLA-5-mediated
modulation of mast cell activation.
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Figure 3. Rafts and FcεRI signaling. A. Organization of the plasma membrane
microdomains. Clusters of liquid-ordered sphingolipids and cholesterol molecules in the
exoplasmic leaflet of the plasma membrane constitute ‘microdomains’ that are dispersed within
the fluid mosaic of the membrane glycerophospholipids. Glycosylphos-phatidylinositol(GPI)-
anchored proteins also cluster in microdomains but most transmembrane proteins, such as
FcεRI, tend to be excluded. Src family PTK Lyn is also found in micro-domains and plays an
essential role in FcεRI signaling. (Adapter from Immunology Today)77 B. FcεRI clustering
induces raft association. On the plasma membrane of nonstimulated mast cells FcεRI is not
associated with rafts. Upon receptor aggregation by multivalent allergen, FcεRI associates with
rafts. Subsequent association of Lyn leads to phosphorylation of FcεRI-β and -γ and triggers the
signal transduction cascade leading to degranulation.
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Scope of this thesis
The investigations presented in this thesis are focussed on the mechanism by
which VLA-5-mediated adhesion to fibronectin modulates mast cell
degranulation.
The experimental setup that is used for the main part of our investigations is
introduced and characterized in chapter 4. We use mast cells that are derived
from murine bone marrow, which are stimulated with Mn2+ to convert VLA-5 into
a high-affinity state and thereby induce adhesion to fibronectin. The effects of
Mn2+-induced adhesion on mast cell degranulation are presented in chapter 6,
and the underlying mechanisms are investigated in more detail in chapter 7.
From the obtained data, we formulate a model in which the extent of high-
affinity conversion of VLA-5 and the subsequent adhesion to fibronectin
correlates with the sensitivity of mast cells for allergen. In chapter 5 we explore
the possibility to block VLA-5 with peptides that should theoretically bind to the
cation-binding domains the α-subunit of this integrin. Finally, the role for the
cholesterol-enriched membrane micromains, rafts, in regulation of mast cell
degranulation is investigated (chapter 3).
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in rat basophilic leukemia cells by serum cholesterol
René Houtman, Merethe Enstad†, Frank A. Redegeld, Andries S.
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Abstract
Mast cells play an important role in hypersensitivity type I responses. Antigenic
challenge of mast cells results in clustering of the high-affinity receptor for IgE
(FcεRI), which leads to tyrosine phosphorylation of the receptor β- and γ-
subunits and protein tyrosine kinases Lyn and Syk and eventually release of
inflammatory mediators. In this study we show that cholesterol from fetal calf
serum is important for the rat mast cell line, RBL-2H3, for sustained
susceptibility towards antigenic challenge. Serum deprivation at 37°C prior to
antigenic stimulation results in a reversible decrease of β-hexosaminidase
release, an effect that becomes more prominent with length of the serum
deprivation interval. Serum deprivation does not affect the viability or IgE-
binding capacity of the cells. Cholesterol is a vital component of membrane
rafts, which have been shown previously to play a role in the initiation of proper
tyrosine phosphorylation following FcεRI clustering. Indeed we find impaired
tyrosine phosphorylation at an early stage of the FcεRI signal transduction
cascade in deprived cells. Although the degree of tyrosine phosphorylation of
FcεRI-β is unaltered, tyrosine phosphorylation of FcεRI-γ, Lyn and Syk, located
downstream in the signaling cascade, is impaired.
In conclusion, our results demonstrate that absence of cholesterol due to serum
deprivation, prior to allergic challenge, affects the FcεRI signaling cascade at an
early stage and thereby attenuates degranulation.
Serum cholesterol modulates the sensitivity of RBL-2H3 cells
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Introduction
Mast cells are localized in virtually all vascularized tissues and play an
important role in inflammation and hypersensitivity type I responses147. Cross-
linking of the high-affinity receptor for IgE (FcεRI)i leads to tyrosine
phosphorylation, phosphoinositol hydrolysis, elevation of cytoplasmic calcium
levels and eventually release of various inflammatory mediators from mast cell
granules59,161.
An increasing number of reports suggest regulatory, mostly enhancing, effects
on mast cells by various micro-environmental factors, possibly by modulation of
the FcεRI signal transduction cascade. For example, integrin-mediated cellular
adhesion to extracellular matrix components such as fibronectin and
laminin62,64,131,167,177, humoral factors such as IL340, soluble stem cell factor
(SCF)29,85,151,156, and interaction with fibroblasts via membrane-bound SCF121
have been reported to enhance degranulation. The number of factors reported
to affect the functional repertoire of mast cells in vitro increases rapidly, and at
least some of these factors may prove to play an important role in the
modulation of mast cell activity in vivo.
Fetal calf serum (FCS) is a widely used but poorly characterized reagent for cell
culture and contains a broad spectrum of proteins, lipids, and other factors.
Serum deprivation has been reported to affect various cell types at the level of
gene expression80,162, synthesis and activity of proteins16,145, and phospholipid
content23,149. Furthermore, serum deprivation has been shown to induce cellular
differentiation, cell cycle-arrest24,169 and impaired cell function140.
In this study, an inhibiting effect of serum deprivation on IgE-mediated
degranulation of rat mast cell line RBL-2H3 is shown. An estimation of the
molecular size based on FCS dialysis using a range of MWCO dialysis
membranes, and cholesterol addition studies, suggest that cholesterol may be a
critical component of serum for the sustained degranulation capacity of RBL-
2H3 cells.
Materials & Methods
Cells
RBL-2H3 cells were cultured in 75 or 162 cm2 flasks at 37°C under humidified air,
containing 5 % CO2, in K-medium: RPMI 1640 supplemented with 10 %(vol/vol) heat-
inactivated FCS, 1 mg/ml gentamycin (Life Technologies B.V., Breda, The
Netherlands), 100 U/ml penicillin/streptomycin, 40 mM L-glutamine (Sigma Aldrich
NV/SA, Axel, The Netherlands) and 0.2 M HEPES. Cells were recultured 2-3 times per
week, by treatment with 0.05 % trypsin/0.53 mM EDTA (Life Technologies B.V., Breda,
The Netherlands) and transferred to new flasks.
Treatment
Cells were incubated in suspension at a density of 1x106/ml, for indicated time intervals
at indicated temperatures in Tyrode’s buffer: 0.1 M Tyrode salts (Life Technologies BV,
Breda, The Netherlands), 100 mM HEPES/ 0.1 % NaHCO3, pH 7.2, supplemented with
                                                          
i For abbreviations see page 101
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0.1 % BSA (Sigma Aldrich NV/SA, Axel, The Netherlands) alone (deprivation) or
supplemented with 10 %(vol/vol) FCS (control, Life Technologies BV, Breda, The
Netherlands) or cholesterol (polyoxyethanyl-cholesteryl sebacate, Sigma Aldrich
NV/SA, Axel, The Netherlands) or FCS dialysis fraction (see below). Subsequently,
cells were washed and resuspended in Tyrode’s/BSA. Cholesterol concentrations
indicated were calculated as 23 % of a polyoxyethanyl-cholesteryl sebacate
concentration, according to supplier information sheet.
Dialysis of FCS
One volume of undiluted FCS (Life Technologies B.V., Breda, The Netherlands)
(“inside fraction”) was dialyzed for 24 hrs at 4°C against four volumes of Tyrode’s buffer
(“outside fraction”) using Spectra/Por dispodialysers (Spectrum Europe B.V., Breda,
The Netherlands) of MWCO 5000, 3500, 2000, 1000, 500 and 100 Da. The residual
inside fraction was separated from the outside fraction and dialyzed for an additional 24
hrs at 4°C against 1 L of Tyrode’s buffer. Obtained inside and outside fractions were
diluted in Tyrode’s/BSA in such way that the concentration of the serum factor in our
fractions corresponded to that in a 10 %(vol/vol) dilution of complete FCS in
Tyrode’s/BSA.
β-Hexosaminidase release
Cells were harvested from culture flasks by treatment with trypsin/EDTA, resuspended
in K-medium and incubated for 60 minutes at 37°C at a density of 1x106/ml with
supernatant of anti-dinitrophenyl (DNP)-specific IgE-producing hybridoma 26.82 (a kind
gift from dr. J. Rivera, NIH, Bethesda, USA)98. Non-bound IgE was removed by
washing and cells were resuspended in Tyrode’s/BSA.
After treatment (as described above), anti-DNP IgE-sensitized cells were seeded on a
96-well plate (Costar Europe Ltd., Badhoevedorp, The Netherlands), at a density of
5x104/well, and stimulated for 30 minutes at 37°C with DNP-HSA (Sigma Aldrich
NV/SA, Axel, The Netherlands). Supernatants of activated cells were collected and
samples of 5x104 cells were lyzed using 0.1 % NP-40 (Omnilabo International, Breda,
The Netherlands) in order to quantify the total granular β-hexosaminidase activity
present in the cells. β-Hexosaminidase activity was determined as described
previously84. In short: samples were incubated for 60 minutes with 4-methylumbelliferyl-
N-acetyl-β-D-glucosaminide (4-MUG, Sigma Aldrich NV/SA, Axel, The Netherlands)
and the reaction was stopped with 0.2 M glycin buffer (pH 10.7). 4-MUG hydrolysis was
determined by fluorimetric measurement (λex: 360nm/λem: 452nm) using a Millipore
Cytofluor 2350. The percentage of degranulation was calculated as follows: 100% x
fluorescencesupernatant/fluorescencecell lysate. All results were corrected for spontaneous β-
hexosaminidase release from cells incubated with reaction buffer only (always <3%).
Viability
To determine membrane integrity, cells were incubated 10 minutes at 37°C with 10 µM
calcein AM (Molecular Probes Europe B.V., Leiden, The Netherlands) and washed.
Cytoplasmic fluorescence was quantified by flow cytometric analysis using FACScan
and PC-lysis software (Becton Dickinson, Leiden, The Netherlands).
To determine mitochondrial activity, cells were incubated for 3 hrs at 37°C, with 50 µM
MTT (Sigma Aldrich NV/SA, Axel, The Netherlands). The reaction was stopped by cell
lysis using acidified isopropanol. Formazan formation was quantified by measuring
OD550nm using a Biorad Benchmark microplate reader.
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Membrane expression of FcεRI
Cells were incubated for 30 minutes at 4°C with FITC-conjugated103 purified 26.82 IgE
in FACS buffer (0.1 % BSA, 0.1 % sodium azide in PBS), washed and resuspended in
FACS buffer. Fluorescence was analyzed by flow cytometry using FACScan, and PC-
lysis software, unstained cells were used as negative control.
Western blot analysis of protein tyrosine phosphorylation
Anti-DNP IgE-sensitized cells were triggered for indicated time intervals at 37°C with
100 ng/ml DNP-HSA, or with buffer only as a negative control. Tyrosine
phosphorylation was stopped by cell lysis using TNT-PLAA: 0.5 % NP-40, 0.15 M
NaCl, 50 mM Tris, 1 mM EDTA, 1 mM sodium orthovanadate (Janssen Chimica;
Tilburg, The Netherlands), 10 mM tetrasodium pyrophosphate, 0.5 mM sodiumfluoride,
1 mM PMSF (Sigma Aldrich NV/SA, Axel, The Netherlands), 10 µg/ml leupeptin, 10
µg/ml aprotinin, 10 µg/ml antipain, (ICN Biochemicals BV, Zoetermeer, The
Netherlands), pH 7.4. After 30 minutes incubation on ice the NP-40-insoluble fraction
was removed by centrifugation. Supernatants were precleared by 30 minutes
incubation with 5 %(vol/vol) prot-G-Sepharose beads, (Pharmacia Biotechnologie,
Roosendaal, The Netherlands). Subsequently, supernatants were immunoprecipitated
using antibodies against phosphotyrosine (PY-20), Lyn (Ab 44), Syk (C-20) (Santa
Cruz Biotechnology Inc, Santa Cruz, USA), FcεRI-β (JRK, a kind gift from dr. J. Rivera,
NIH, Bethesda, USA), or FcεRI-γ (a generous gift from dr. M. -H. Jouvin, Boston, USA)
and 5 %(vol/vol) prot-G-Sepharose beads. Beads were washed 4 times with TNT-
PLAA and resuspended in SDS-sample buffer: 3 % SDS, 7.5 %(vol/vol) glycerol, 0.05
M Tris and 0.5 mg/ml bromophenol blue.
Samples were boiled for 3 minutes with 10 mM DTT (Sigma Aldrich NV/SA, Axel, The
Netherlands), separated on 12.5 % bis-/acrylamide gel (Bio-Rad Laboratories BV,
Veenendaal, The Netherlands) and blotted on PVDF membrane (Costar Europe Ltd.,
Badhoevedorp, The Netherlands). Phosphorylation of blotted proteins was visualized
using HRP-conjugated PY-20 (Santa Cruz Biotechnology Inc, Santa Cruz, USA), ECL
chemiluminescence (Amersham Nederland B.V., Den Bosch, The Netherlands), and
exposure to KODAK X-OMAT-AR film. Films were scanned and analyzed on Bio-Rad
GS-670 and Molecular Analyst software (Bio-Rad Laboratories BV, Veenendaal, The
Netherlands).
Results
Effect of serum deprivation on IgE-mediated β-hexosaminidase release by
RBL-2H3
In our experiments using RBL-2H3 cells in a model for mast cell degranulation,
we observed that incubation of our cells at 37°C in Tyrode’s buffer (hereafter
referred to as deprivation) prior to antigenic stimulation leads to decreased β-
hexosaminidase release. This phenomenon becomes more prominent with
increased length of serum deprivation. As is shown in figure 1A, cells that were
incubated in Tyrode’s buffer for 15, 30, 60 or 90 minutes at 37°C show decreased
degranulation. Maximal degranulation is decreased more than 50% after 90
minutes incubation. As a control we performed the same incubation of cells
however in buffer supplemented with 10 %(vol/vol) FCS (comparable to culturing
conditions). As is shown in figure 1B, decrease of mediator release could not be
observed when cells were incubated in the presence of serum. We conclude that
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serum deprivation leads to decreased IgE-mediated degranulation in a time-
dependent manner.
Effect of serum deprivation-temperature on β-hexosaminidase release
Our cells show decreased degranulation after serum deprivation performed at
37°C, and we were interested if this effect was temperature-dependent. To
investigate this we compared IgE-mediated degranulation of cells deprived for 90
minutes at 4°C, or at 37°C and cells incubated for 90 minutes at 37°C in the
presence of 10 %(vol/vol) FCS (control cells). As is shown in figure 2, serum
deprivation at 37°C leads to decreased degranulation, but cells deprived at 4°C
Figure 1. Effect of preincubation in absence or presence of FCS on IgE-induced β-
hexosaminidase release of RBL-2H3 cells. Anti-DNP IgE-sensitized cells were incubated at
37°C in Tyrodes buffer without (A) or with (B) 10 %(vol/vol) FCS for indicated time periods and
stimulated with DNP-HSA. After 30 minutes β-hexosaminidase release was measured. Mean ±
s.e.m. of a representative experiment of triplicates are shown.
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Mean ± s.e.m. of a representative of three
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show levels of β-hexosaminidase release that are comparable to control cells. We
conclude that serum deprivation leads to decreased IgE-mediated degranulation
in RBL-2H3 cells via a mechanism that takes place at a physiological temperature
of 37°C, but not at 4°C.
Effect of addition of FCS after serum deprivation on β-hexosaminidase
release
Decreased degranulation after serum deprivation was shown to become more
pronounced with time and we were interested if this effect is reversible. To
investigate this we compared IgE-mediated β-hexosaminidase release of deprived
cells, cells that after serum deprivation were incubated for an additional 90
minutes in buffer supplemented with 10 %(vol/vol) FCS, and control cells. Figure 3
shows that the decrease of degranulation observed after serum deprivation can
be completely reversed by administration of FCS to deprived cells, because
degranulation of these cells is comparable to that of control cells. We conclude
that the effect of serum deprivation on degranulation can be reversed by
administration of serum to deprived cells.
Determination of the approximate size of the serum component
To elucidate the identity of the serum component responsible for the observed
phenomena, our goal was to achieve an estimation of its size. For this purpose
samples of FCS were dialyzed using a range of dialysis membranes of different
pore size. Via this approach, dialysis of FCS with MWCO 5000 membrane results
in an inside fraction containing serum components larger than 5000 Da and an
outside fraction containing all serum components with a molecular weight below
5000 Da. Decrease of pore size will eventually lead to a loss of the factor of
interest from the outside fraction. As is shown in figure 4, cells incubated with the
outside fractions of MWCO higher than 1000 Da retain optimal sensitivity towards
antigenic challenge (comparable to cells incubated with 10 %(vol/vol) FCS, data
not shown) indicating that the serum component of interest has a molecular
weight below 1000 Da. Using dialysis membranes with MWCO <1000 Da the
critical serum component was largely retained in the inside and depleted from the
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hexosaminidase release of deprived RBL-
2H3 cells. Anti-DNP IgE-sensitized cells were
incubated for 90 minutes at 37°C in Tyrodes
buffer with (control) or without 10 %(vol/vol)
FCS (deprivation). One group of deprived
cells was incubated additionally for 90
minutes at 37°C with 10 %(vol/vol) FCS
(readdition), followed by stimulation with
DNP-HSA. After 30 minutes β-
hexosaminidase release was measured.
Mean ± s.e.m. of a representative experiment
of quadruplicates are shown (in all cases
error bars are covered by symbols).
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outside fraction. From these results we conclude that the critical serum factor has
a molecular weight below 1000 Da.
Effect of replacement of FCS by cholesterol during serum deprivation on
β-hexosaminidase release
Based on the estimation of a molecular size below 1000 Da combined with data
from literature, several candidate agents were tested. All agents tested failed to
prevent decreased degranulation when replacing FCS during serum deprivation
(data not shown), except for cholesterol. As is shown in figure 5, the loss of
sensitivity towards antigenic challenge could be prevented by addition of
cholesterol in a dose-dependent manner. Degranulation comparable to control
cell was achieved when a concentration of 12 µg/ml polyoxyethanyl-cholesteryl
sebacate was used. Cells incubated with a higher concentration of cholesterol
showed even increased degranulation, compared to control cells. From these
data we conclude that decreased degranulation by serum deprivation can be
prevented by addition of cholesterol.
Figure 4. Effect of addition of FCS-dialysis
samples during serum deprivation on β-
hexosaminidase release of RBL-2H3 cells.
Different samples of 10 %(vol/vol) FCS were
dialyzed with filters of various pore size,
resulting in an inside and an outside fraction
(see materials & methods). Prior to antigenic
stimulation, anti-DNP IgE-sensitized cells
were incubated for 90 minutes at 37°C with
the resulting fractions. Subsequently cells
were stimulated with 30 ng/ml DNP-HSA and
after 30 minutes β-hexosaminidase release
was measured. Mean ± s.e.m. of a
representative experiment of quadruplicates
are shown. (In several cases, error bars are
covered by symbols used)
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cholesterol during serum deprivation on β-
hexosaminidase release of RBL-2H3 cells.
Prior to antigenic stimulation, anti-DNP IgE-
sensitized cells were incubated for 90 minutes
at 37°C in Tyrodes buffer with 10 %(vol/vol)
FCS or various concentrations of cholesterol.
Subsequently cells were stimulated with 30
ng/ml DNP-HSA. After 30 minutes β-
hexosaminidase release was measured.
Mean ± s.e.m. of a representative of three
independent experiments of quadruplicates
are shown. The cholesterol concentration was
calculated as indicated in materials and
methods.
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Effect of serum deprivation on cell viability
One explanation for the observed phenomena of serum deprivation could be
that the condition of the cells is affected thereby influencing their
responsiveness towards antigenic challenges. To exclude this possibility we
compared deprived and control cells in several tests which are indicative for cell
viability.
The ability of cells to retain cytoplasmic components is impaired in cells with
decreased viability due to reduced membrane integrity. Cells were loaded with
calcein AM, which is cleaved to fluorescent calcein by cytoplasmic esterases96,
and cytoplasmic fluorescence was determined as a measure for viability.
Decreased cell viability correlates directly with loss of mitochondrial activity of
the cell. Therefore, we analyzed the cleavage of MTT into formazan by the
succinate-tetrasodium reductase system, which belongs to the respiratory chain
of mitochondria115, as a second parameter for the viability of deprived cells.
Table I shows that cell membrane integrity as well as mitochondrial activity is
comparable in deprived and control cells. This indicates that cell viability is not
affected by serum deprivation and therefore cannot be the reason for the
observed effect on degranulation.
Effect of serum deprivation on IgE binding capacity of the cells
To investigate if serum deprivation leads to either decreased FcεRI membrane
expression or decreased affinity for IgE, the binding of FITC-conjugated IgE to
control and deprived cells was compared via flow cytometry. In figure 6
histograms of FITC conjugated IgE binding to control and deprived cells are
shown. No difference in fluorescence between control and deprived cells can be
observed indicating that the ability of RBL-2H3 to bind IgE is not affected by
serum deprivation
control
deprivation
Table 1. Comparison of viability of
deprived and control cells. RBL-2H3 cells
were incubated for 90 minutes at 37°C in the
presence or absence of 10 %(vol/vol) FCS
and subsequently analysed for mitochondrial
activity (OD550) and membrane integrity
(cyoplasmic fluorescence). Mean arbitrary
units ± s.e.m. of a respresentative experiment
performed in quadruplicate are shown.
Figure 6. Effect of serum deprivation on
IgE binding capacity of RBL-2H3. Control
and deprived cells were incubated for 1 hr at
37ºC with FITC-conjugated IgE. Cells were
washed to remove unbound IgE-FITC and
analyzed by FACScan. Nonstained cells were
used as negative control. A representative
example of four independent experiments is
shown.
mitochondrial
activity
membrane
integrity
control 1.24 ± 0.04 422 ± 1
deprivation 1.22 ± 0.07 419 ± 8
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Effect of serum deprivation on FcεRI-mediated tyrosine phosphorylation
To test the effect of serum deprivation on FcεRI signal transduction, overall
protein tyrosine phosphorylation patterns were obtained after antigenic
stimulation of control and deprived cells for various periods of time followed by
immunoprecipitation with anti-phosphotyrosine Ab (PY20) and Western blot
analysis using the same antibody. As is shown in figure 7, maximal tyrosine
phosphorylation of the majority of proteins is reached within 2 minutes after
stimulation in both control and deprived cells. Importantly, tyrosine
phosphorylation of the majority of proteins is impaired in deprived cells (right
panel) compared to control cells (left panel). Because phosphorylation of a large
number of proteins is affected it appears to be likely that serum deprivation
affects the FcεRI signaling pathway at an early stage.
Effect of serum deprivation on tyrosine phosphorylation of FcεRI-β, Lyn,
FcεRI-γ, and Syk
In order to be more accurate on the locus within the FcεRI pathway affected by
serum deprivation, we decided to study tyrosine phosphorylation of FcεRI-β,
Lyn, FcεRI-γ, and Syk, which have been established as the first sequential steps
of FcεRI signaling following receptor clustering by multivalent antigen14.
Immunoprecipitates using Abs against each of these proteins separately were
analyzed for tyrosine phosphorylation via Western blot analysis using PY20. As
is shown in figure 8A, in deprived as well as control cells maximal tyrosine
phosphorylation of FcεRI-β, Lyn, FcεRI-γ and Syk is reached within 2 minutes
after stimulation. Importantly, the degree of phosphorylation of each of these
proteins in control and deprived cells is not comparable. Densitometric analysis
of phosphorylation signals at 2 minutes after stimulation, in figure 8B, shows
that tyrosine phosphorylation of FcεRI-β is largely unaffected. However when
comparing the degree of phosphorylation of Lyn, FcεRI-γ and Syk in deprived
cells and control cells we observe an increased reduction in deprived cells of
40, 65 and 90% respectively. It should be noted that, although no tyrosine
phosphorylation of FcεRI-γ is optically visible, densitometric analysis showed
increase of density after background subtraction of the film. Measured densities
IP and blot: anti-phosphotyrosine
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Figure 7. Effect of serum deprivation on
tyrosine-phosphorylation in RBL-2H3
cells. Anti-DNP IgE-sensitized cells were
incubated for 90 minutes at 37°C in Tyrodes
buffer with (control) or without 10 %(vol/vol)
FCS (deprivation). Cells were stimulated for
indicated time periods with 100 ng/ml DNP-
HSA and lyzed after indicated time periods.
Cell lysates were immunoprecipitated using
anti-phosphotyrosine antibody PY-20, and
immunoprecipitates were analyzed by
Western-blotting using HRP-conjugated PY-
20 and chemiluminescence.
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were used, after local background subtraction, to calculate arbitrary units of
tyrosine phosphorylation: densitydeprived cells/densitycontrol cells. These data indicate
that serum deprivation decreases degranulation by affecting the signaling
events that occur immediately after FcεRI clustering.
Discussion
It is well-established that the functional repertoire of the mast cell is influenced
by various factors from its microenvironment40,131. In this report, we demonstrate
that continuous presence of serum is needed for RBL-2H3 to maintain
sensitivity towards antigenic challenges, and that cholesterol is most likely the
factor responsible for this effect.
Our data on membrane integrity and mitochondrial activity indicate that the
viability of deprived cells is comparable to control cells and therefore reduced
viability can not be an explanation for the phenomenon observed here.
Furthermore we found that the ability of deprived cells to bind IgE is comparable
to control cells, and therefore decreased degranulation is not due to an altered
FcεRI receptor affinity for IgE or amount of receptors expressed on the
membrane.
We tested lysophosphatidic acid (max. conc.: 10 µM), ADP, ATP (max. conc.: 1
mM) and glutathione (oxidized and reduced, max. conc. 3 mg/L) as possible
candidates, but all fail to prevent decreased degranulation after deprivation
(data not shown).
On the other hand, the replacement of serum by cholesterol does prevent
decrease of degranulation, and several arguments support our conclusion that
cholesterol plays a key role in the observed phenomena. First, the molecular
size of cholesterol, 386.7, corresponds with our conclusions drawn from the
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blot: anti-phosphotyrosine
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Figure 8. Effect of serum deprivation of tyrosine phosphorylation of FcεRI-β, FcεRI-γ, Lyn
and Syk in RBL-2H3 cells. (A.) Anti-DNP IgE-sensitized cells were incubated for 90 minutes at
37°C in Tyrodes buffer with (control) or without 10 %(vol/vol) FCS (deprivation). Cells were
stimulated for indicated time periods with 100 ng/ml DNP-HSA and lyzed after indicated time
periods. Cell lysates were immunoprecipitated with antibodies against FcεRI-β, FcεRI-γ, Lyn or
Syk, and immunoprecipitates were analyzed by Western-blotting using HRP-conjugated PY-20
and chemiluminescence. (B) Obtained signals on film from cells stimulated for 2 minutes were
quantified using a Bio-Rad GS-670 densitometer. Tyrosine phosphorylation of each investigated
protein was compared to that in control cells. Arbitraty units tyrosine phosphorylation (A.U. PY)
were obtained by dividing the ODPY of each protein by the ODPY of that protein in control cells.
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dialysis experiments stating that the serum factor should be smaller than 1000
Da. Second, we found in our experiments that cells incubated with 12 µg/ml
cholesterol (23% of 50 µg/ml polyoxyethanyl-cholesteryl sebacate, according to
the manufacturers datasheet) during deprivation showed degranulation
comparable to cells incubated with complete FCS. This concentration lies in the
same order of magnitude as the concentration of cholesterol found in FCS (22-
38 µg/ml in 10 %(vol/vol) suspension according to supplier’s information).
Importantly, cholesterol has been shown to be an important component of
detergent-resistant plasma membrane structures20 also known as rafts, which
have been shown to play a critical role in FcεRI signaling47-49,143,144,152. Our data
show that serum deprivation affects degranulation in a time- and temperature-
dependent manner. It is tempting to speculate that, if normal physiologic cell
metabolism results in depletion of the endogenous cholesterol pool and cells fail
to replenish this pool due to lack of a cholesterol source this leads to decreased
efficiency of raft formation.
FcεRI aggregation induces a shift in Lyn distribution towards rafts47,143,144. We
find that tyrosine phosphorylation of Lyn is impaired in serum deprived cells and
decreased Lyn recruitment and phosphorylation could be the result of impaired
formation of functional Lyn-containing membrane microdomains. Availability of
Lyn to the early FcεRI signaling complexes may be rate-limiting for FcεRI
induced degranulation158,173. We find that activation of “downstream” components
of the FcεRI signaling cascade is progressively less effective in deprived cells,
which is consistent with the concept of “kinetic proofreading”71,120, which also
applies for FcεRI signaling159. This concept states that a cascade of intracellular
events unfold as long as the initiating event is maintained. It has been
postulated that the biological potency of an individual FcεRI receptor is
determined by its lifetime within a signaling aggregate, and this lifetime could be
affected by attenuated raft formation in deprived cells.
Previous reports have shown that Syk tyrosine phosphorylation and induction of
its kinase activity is essential for mast cell degranulation32,132. The decreased
degranulation observed in this study could be easily explained as a direct
consequence of decreased Syk activation in deprived cells.
Membrane cholesterol levels appear to play a role in the activation of RBL-2H3
cells. To maintain these levels cells can also use cholesterol-precursors for de
novo synthesis of cholesterol. Interestingly, inhibition of cholesterol biosynthesis
by lovastatin was shown to reduce FcεRI-induced tyrosine phosporylation and
blocks serotonin release of RBL-2H337,142. We can not exclude the possibility
that the serum component, which upon serum withdrawal leads to the observed
phenomena, is a cholesterol-precursor instead of cholesterol. However, since
cells can use the uptake of complete cholesterol to maintain their cellular levels
this option seems unlikely.
In conclusion, we show in this study that serum deprivation results in decreased
degranulation in RBL-2H3. We propose that this decrease is the result of the
absence of cholesterol thereby disturbing the formation of membrane rafts and
attenuation of the coupling between cross-linking of the receptor and the
pathway leading to mediator release from mast cell granules. These results
provide us with possible new insights into the fine-tuning of mast cell
degranulation by microenvironmental factors.
Development and characterization of an in vitro murine
model to study modulation of FcεRI-induced mast cell
degranulation through VLA-5-mediated adhesion to
fibronectin
René Houtman, Khalil Karimi, Frank A. Redegeld, Andries S. Koster
and Frans P. Nijkamp
(Submitted for publication)
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Abstract
Mast cells play an important role in allergic responses. Release of inflammatory
mediators from mast cell granules cells, triggered by antigenic stimulation, can
be modulated by adhesion to fibronectin via integrin very late antigen-5 (VLA-5).
Investigation of the molecular basis of this modulation requires an in vitro model
system in which adhesion and degranulation can be controlled independently.
Here, a novel model that meets these criteria, is presented and characterized.
We show that adhesion of mast cells derived from murine bone marrow to
fibronectin can be induced by Mn2+-stimulation and that this adhesion is
mediated via VLA-5. The mechanism involved can be divided into two stages.
During the first stage, a high-affinity conformation of VLA-5 is induced by Mn2+
and adhesion to fibronectin is enabled. This effect can be antagonized by
extracellular Ca2+. During the second stage, which is temperature-sensitive and
can be attenuated by kinase and phosphatase inhibitors, intracellular signaling
strengthens the cell-substrate bond. After attachment of the cells to fibronectin
is established, we found that adhesion is no longer affected by the presence of
extracellular Ca2+. This makes adhered cells available for degranulation
experiments for which influx of Ca2+ is critical. By using polystyrene beads as
carrier for immobilized fibronectin, this setup can also be applied for
biochemical analysis of adhered cells when larger amounts of cells are needed.
In conclusion, we present a novel in vitro model that can be used to investigated
the molecular basis of VLA-5-mediated modulation of allergen-induced mast cell
degranulation.
 In vitro mast cell model to study VLA-5-FcεRI interaction
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Introduction
Mast cells play an important role in allergic responses147. First encounter with an
allergen activates the immune system and results in the production of allergen-
specific IgE, which binds to the high-affinity receptor for IgE (FcεRI)i expressed
on mast cells. Second encounter with the allergen induces clustering of FcεRI161
and triggers a signal transduction cascade leading to degranulation of various
inflammatory mediators, which cause clinical phenomena associated with
allergy12,14,59.
Mast cells are localized in all vascularized tissues and an increasing number of
reports suggest that the function of these cells is affected by their
microenvironment consisting of neighboring cells, extracellular matrix and
various humoral factors39,56,134,155. Understanding of the mechanism by which
microenvironmental factors modulate mast cell degranulation is potentially
useful for the development of future therapy against allergy.
Adhesion to extracellular matrix component fibronectin has been shown to
enhance FcεRI-induced degranulation of RBL-2H3 mast cells62,64,131,155. Although
it was shown that this adhesion is mainly mediated by α5β1 integrin very late
antigen-5 (VLA-5) and the arginine-glycine-aspartic acid (RGD) sequence of
fibronectin150,177, the mechanism by which FcεRI signaling is influenced is not yet
understood in detail.
In order to be able to study the molecular basis of VLA-5-mediated modulation
of FcεRI signaling, an in vitro model system is required of which VLA-5-
mediated adhesion and FcεRI-induced degranulation can be controlled
independently.
RBL-2H3 cells, a widely used model for mast cells, adhere to various surfaces
without assembling specialized adhesion structures at the cell-substrate
interface8,124 and are therefore, in our opinion, not a suitable model to study the
effect of adhesion on degranulation. We prefer to use mast cells cultured from
mouse bone marrow (BMMC)84,133 because these cells do not show nonspecific
adhesion. Although it has been shown that VLA-5 is expressed on BMMC,
these cells do not adhere spontaneously to fibronectin45,177. It has been
demonstrated that on resting cells, integrins exist in a low-affinity conformation
and that inside-out signaling is needed for the conversion of these receptors
into a high-affinity state44,46,55,74,93. This suggests that stimulation of BMMC is
necessary in order to induce VLA-5-mediated adhesion to fibronectin. Indeed it
was shown that stimulation of BMMC with phorbol myristate acetate (PMA)
induces VLA-5-mediated adhesion to fibronectin, via a phosphatidyl inositol 3-
kinase-dependent pathway87. Besides PMA41,  various integrin-stimulating
agents are known such as ionomycin67, stem cell factor13,36 and antigenic
stimulation87. However, these stimuli directly modulate the FcεRI signaling
cascade leading to degranulation and we therefore prefer not to use them in our
protocols15,157.
Additonally, it was demonstrated in K562 erythroleukemia cells, that the affinity
of VLA-5 for fibronectin can also be modulated by cations. Through binding of
Mn2+ to cation-binding motifs in the extracellular domain of the VLA-5 α-subunit,
a conformational change of the integrin and thereby high-affinity for fibronectin
                                                          
i For abbreviations see page 101
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is induced. This effect is antagonized by Ca2+ 116,118. Additionally, integrin-ligand
binding is stabilized by the cooperative coordination and binding of Mn2+ by the
negatively charged amino acid residues of the cation binding domain localized
in the ligand binding area of VLA-5 and the negatively charged aspartic acid of
the RGD-sequence in fibronectin7. Soluble RGD peptide has been shown to
block mast cell adhesion to fibronectin36,155,175. Binding to fibronectin induces
clustering of VLA-5 which triggers the activation of tyrosine kinases and
phosphatases, and subsequent formation of focal adhesion complexes at the
site of integrin clustering which strengthens the cell-fibronectin interaction22,58.
In this report we use cations to regulate VLA-5-mediated adhesion of BMMC to
fibronectin. The mechanism involved is characterized and the potential to apply
this protocol as a new model to study VLA-5-mediated modulation of FcεRI-
induced degranulation of mast cells is evaluated.
Materials & Methods
Cells
BMMC were obtained as described previously84. Briefly, bone marrow from femurs of
Balb/c mice was flushed and cells were cultured at a density of 2 x 105/ml in complete
RPMI (RPMI1640 medium containing 4 mM L-glutamine, 5 x 10-5 M β-mercaptoethanol,
1 mM sodium pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.1 mM
nonessential amino acids) supplemented with 20 %(vol/vol) culture supernatant from
Balb/c splenocytes which were stimulated for 7-days with pokeweed mitogen (Sigma
Aldrich NV/SA, Axel, The Netherlands) in complete RPMI. Medium was refreshed once
per week.
Reagents
VLA-5 blocking antibody BMA5 was a kind gift from Dr B.M.C. Chan, Transplantation
and Immunobiology group, Univ. Western Ontario, Canada45. RGD-peptide and
phenylarsene oxide (PAO) were purchased from Sigma Aldrich NV/SA, Axel, The
Netherlands. Genistein was purchased from Sanvertech B.V. Heerhugowaard, The
Netherlands.
Immobilization of fibronectin
NUNC maxisorp 96 well plates were coated for 3 hours at 37°C with 2.5 mg/ml human
fibronectin (CLB, Amsterdam) in PBS, 200 µl/well, washed 3 times with 200 µl/well
PBS, and used for adhesion experiments.
Latex beads (average diameter 11.9 µm, Sigma Aldrich NV/SA, Axel, The Netherlands)
were incubated for 1 hour at room temperature with 2.5 mg/ml human fibronectin in
PBS, under constant rotation, followed by three times washing with an excess volume
of PBS and used for fluorescence microscopy experiments.
Loading of cells with 4-(and-5)-carboxyfluorescin diacetate
The cytoplasm of the BMMC was stained with the fluorescent product of 4-(and-5)-
carboxyfluorescin diacetate (4(5)CFDA) hydrolyzed by cytoplasmic esterases. Cells
 In vitro mast cell model to study VLA-5-FcεRI interaction
39
were washed twice with FCS-free culture medium and incubated for 25 minutes at
37°C with 10 mM 4(5)CFDA. Subsequently, cells were washed twice with complete
culture medium and prepared for adhesion.
Adhesion of BMMC to fibronectin
4-6 week old BMMC were washed once with PBS, once with 1 mM EDTA in PBS at
37°C, and once with tris-buffered saline (TBS, 2.9 g/L Tris-Cl, 4 g/L NaCl, 0.2 g/L KCl,
0.4 g/L glucose, 0.1 % BSA) and resuspended at a density of 5 x 105 cells/ml TBS.
For adhesion to fibronectin-coated 96 well plate, per well 100 µl of cell suspension was
incubated with 100 µl of the indicated agent in TBS for 30 minutes on ice, followed by
an incubation at 37°C. After the indicated incubation interval, nonadhered cells were
removed by three times washing with 200 µl/well PBS.
For adhesion to beads, 4(5)CFDA-loaded cells were prepared for adhesion as
described and resuspended at a density of 1 x 107 per ml. Next, cells were stimulated
with 0.2 mM MnCl2, mixed with a pellet of fibronectin-coated beads (beads:cells ratio =
1:1) and centrifuged to pellet the cell/bead mixture. The cell/bead pellet was incubated
at 37°C for 5 minutes, gently resuspended and incubated for an additional 25 minutes
at 37°C. Cell/bead complexes were fixed with paraformaldehyde (final concentration of
1%) and mounted on object slides using Vectashield Mounting medium (Molecular
Probes Europe B.V., Leiden, The Netherlands) and cover slides. Samples were
examined microscopically using a Nikon Eclipse E600 with Nomarski optics and
epifluorescence (filters: λex: 465-95/ λem: 515-55), and recorded digitally using an
Apogee KX2 camera (Lambert Instruments B.V.) and processed with Adobe Photoshop
4.0.
Quantification of adhesion
Adhesion was quantified using Cyquant proliferation assay kit (Molecular Probes
Europe B.V., Leiden, The Netherlands) according to the manufacturer’s protocol. In
short, plates were frozen overnight at -20°C, thawed and incubated for 60 minutes
under continuous agitation at room temperature with a DNA-specific fluorescent dye
and lysing reagent. Fluorescence was measured at λex.: 485nm/λem.: 530nm using a
Millipore Cytofluor 2350 and adhesion was calculated as the residual fluorescence as
percentage of input fluorescence.
Results
Cation-induced modulation of adhesion of BMMC to fibronectin
To test if cation-induced modulation of VLA-5 affinity for fibronectin116 can be
extrapolated to BMMC, we investigated the effect of Mn2+ on adhesion of
BMMC to fibronectin. Extracellular Ca2+ was removed by EDTA-treatment of the
cells. Next, cells were incubated with various concentrations of MnCl2 on a
fibronectin-coated 96 well plate for 30 minutes on ice to synchronize adhesion.
Additionally, cells were incubated for 30 minutes at 37°C and nonadhered cells
were removed by washing. Adhered cells were lysed, DNA was fluorescently
stained and quantified as a measure for the amount of residual cells and %
adhesion was calculated. Figure 1A shows that Mn2+ dose-dependently induces
adhesion of BMMC to fibronectin, reaching maximal adhesion at 0.2 mM MnCl2.
Subsequent experiments were performed as described above unless otherwise
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indicated. Adhesion to non-coated surfaces was never observed (data not
shown).
To investigate if Ca2+ can antagonize Mn2+-induced adhesion, EDTA-treated
BMMC were incubated on immobilized fibronectin with 0.2 mM MnCl2 and
various concentrations of CaCl2. Figure 1B shows that Ca2+ dose dependently
inhibits Mn2+-induced adhesion of BMMC to fibronectin.
Effect of VLA-5 blocking on Mn2+-induced adhesion
To confirm that adhesion of BMMC to fibronectin is mediated by VLA-5 we
tested the effect of VLA-5-blocking antibody, BMA5, and the effect of soluble
RGD on Mn2+-induced adhesion. BMMC were prepared for adhesion, stimulated
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Figure 1. Effect of MnCl2 on the adhesion of BMMC to fibronectin. BMMC were washed
with 1 mM EDTA and incubated on fibronectin-coated 96 well plate (A) with (0-0.5 mM) MnCl2
or (B) with 0.2 mM MnCl2 and (0-0.1 mM) CaCl2 in TBS for 30 minutes on ice, followed by 30
minutes incubation at 37°C. Nonadhered cells were removed by washing, adhered cells were
lyzed and quantified by fluorescent staining of DNA. % Adhesion was calculated from residual
fluorescence compared to input fluorescence. (In several case error bars are covered by
symbols used).
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Figure 2. Effect of BMA5 and RGD-peptide
on adhesion of BMMC to fibronectin.
BMMC prepared for adhesion as described,
were incubated with 15 µg/ml BMA5 for 60
minutes on ice before, or various
concentrations of RGD-peptide during the
incubation on a fibronectin-coated 96 well
plate, 30 minutes on ice and 30 minutes at
37°C. Nonadhered cells were removed by
washing and adhesion was quantified. %
Control adhesion was calculated from the
absolute adhesion of MnCl2-stimulated cells
treated with BMA5 or RGD compared to cells
stimulated with MnCl2 alone.
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with MnCl2 and incubated with either BMA5 1 hour before, or various
concentrations of RGD-peptide during the incubation on immobilized fibronectin.
The percentage of inhibtion was calculated from the absolute adhesion of
MnCl2-stimulated cells treated with RGD or BMA5, compared to the absolute
adhesion of cells stimulated with MnCl2 alone. As is shown in figure 2, both
BMA-5 and RGD are able to almost completely inhibit MnCl2-induced adhesion
of BMMC to fibronectin indicating a role for VLA-5.
Effect of a subphysiological temperature on adhesion of BMMC to
fibronectin
In vivo integrin adhesion involves intracellular signaling events that take place
under strict physiological conditions. To investigate if Mn2+-induced adhesion of
BMMC to fibronectin also involves intracellular signaling, we tested the effect of
lowering of the temperature to a nonphysiological level on adhesion.
MnCl2-stimulated BMMC were incubated on immobilized fibronectin on ice for
30 minutes. Additionally, one group of cells was transferred to 37°C while a
second group of cells was kept on ice. As is shown in figure 3, Mn2+-induced
adhesion on ice is severely impaired compared to adhesion at 37°C.
Role for protein tyrosine kinases in Mn2+-induced adhesion of BMMC to
fibronectin
The observation that MnCl2-induced adhesion is temperature-sensitive suggests
intracellular signaling, probably through induction of intracellular enzyme activity
during this process. Phosphorylation of tyrosine residues of various proteins by
protein tyrosine kinases (PTK) has been shown to be a prominent characteristic
for integrin-mediated adhesion100,139. To determine a possible role for PTK, we
tested the effect of PTK inhibitor, genistein, in our setup.
BMMC were stimulated for adhesion and and incubated with various
concentrations of genistein on immobilized fibronectin. Figure 4 shows that
genistein dose-dependently inhibits adhesion of BMMC to fibronectin, indicating
a role for PTKs.
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Figure 3. Comparison of adhesion of
BMMC incubated on ice vs. 37°C. BMMC
were prepared for adhesion as described and
incubated on fibronectin-coated 96 well plate
for 60 minutes on ice (ice) or for 30 minutes
on ice followed by 30 minutes at 37°C (37°C).
Additionally, nonadhered cells were removed
by washing and % adhesion was quantified.
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Role for protein phosphatases in Mn2+-induced adhesion of BMMC to
fibronectin
In cell signaling involving tyrosine phosphorylation, the action of kinases is often
counteracted by phosphatases75. To study if dephosphorylation of proteins by
phosphatases plays a role in Mn2+-induced adhesion, we tested the effect of
phosphatase inhibitor, phenylarsene oxide (PAO), in our setup.
BMMC, prepared for adhesion, were stimulated with Mn2+ and incubated with
various concentrations of PAO on immobilized fibronectin. As is shown in figure
5, PAO dose-dependently attenuates Mn2+-induced adhesion of our cells to
fibronectin, which shows that phosphatases participate in adhesion of BMMC to
fibronectin.
Effect of Ca2+ on sustained adhesion of BMMC to fibronectin
Influx of extracellular Ca2+ was shown to be critical for mast cell degranulation11,
however our data show that the presence of Ca2+ has an inhibiting effect on the
induction of adhesion of BMMC to fibronectin. We tested if administration of
Ca2+, in a concentration that is normally used in protocols for degranulation
experiments, to already adhered BMMC leads to deadhesion of these cells.
Three groups of BMMC were prepared for adhesion and stimulated with MnCl2
on immobilized fibronectin as described above. After 30 minutes of incubation at
37°C nonadhered cells of the first group (30’Mn) were removed by washing, to
the second group (30’Mn/30’Ca) Ca2+-supplemented buffer was added, and the
third group of cells (60’Mn) was left untreated. After an additional incubation of
30 minutes at 37°C, the nonadhered cells of the second and third group were
removed by washing and the adhesion of all three groups was determined. As
is shown in figure 6, Mn2+-induced adhesion after 60 minutes (60’Mn) was
Figure 4. Effect of genistein on adhesion of
BMMC to fibronectin. BMMC were prepared
for adhesion and incubated on a fibronectin-
coated 96 well plate with 0.2 mM MnCl2 and
various concentrations of genistein, for 30
minutes on ice and 30 minutes at 37°C.
Nonadhered cells were removed by washing,
adhesion was quantified and % control
adhesion was quantified.
Figure 5. Effect of PAO on adhesion of
BMMC to fibronectin. BMMC were prepared
for adhesion and incubated on a fibronectin-
coated 96 well plate with 0.2 mM MnCl2 and
various concentrations of PAO, for 30
minutes on ice and 30 minutes at 37°C.
Nonadhered cells were removed by washing
and adhesion was quantified.
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increased compared to 30 minutes incubation (30’Mn), which indicates that from
30 to 60 minutes after the start of adhesion de novo adhesion still takes place.
The adhesion of the group that was treated with Ca2+ after 30 minutes
(30’Mn/30’Ca) is comparable to the adhesion after 30 minutes (first group). This
observation suggests “freezing” of the adhesion process in which adhered cells
are unaffected and remain adhered, while de novo adhesion is prevented by the
presence of Ca2+.
Adhesion of BMMC to fibronectin-coated beads
For practical reasons we explored the possibility to modify our protocol into a
setup in which polystyrene beads instead of 96 well plate are used as a carrier
of immobilized fibronectin.
BMMC were activated for adhesion and incubated with fibronectin-coated
polystyrene beads for 30 minutes at 37°C. Cell-bead complexes were fixed, and
analyzed microscopically. Figure 7A shows a representative example of a
BMMC adhered to a fibronectin-coated bead, both visualized by light
microscopy. To distinguish between cells and beads, BMMC were loaded with
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Figure 6 Effect of Ca2+ on adhered cells.
BMMC were prepared for adhesion and
incubated with 0.2 mM MnCl2 on a
fibronectin-coated 96 well plate for 30 minutes
on ice and subsequently at 37°C. After 30
minutes, of the first group (30’Mn)
nonadhered cells were removed by washing,
to a second group (30’Mn/30’Ca) Ca2+-
supplemented buffer (final concentration: 1.8
mM) was added and the third group was left
untreated. After 60 minutes nonadhered cells
of the second and third group were removed
by washing and % adhesion of all three
groups was determined.
A B
Figure 7. Adhesion of BMMC to FN-coated beads. 4(5)CFDA-loaded BMMC were prepared
for adhesion, stimulated with 0.2 mM MnCl2 and incubated with fibronectin-coated beads for 30
minutes at 37°C. (A) Example of a BMMC (C) adhered to a latex bead (F) detected by light
microscopy and (B) the same example detected by epifluorescence.
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4-(and-5)-carboxyfluorescin, which is cleaved into a fluorescent product by
cytoplasmic esterases. Figure 7B shows the same cell-bead complex as shown
in figure 7A, visualized by epifluorescence. In this figure the fluorescently
stained cytoplasm of the cell is clearly visible, while the contours of the bead
can only vaguely be distinguished. Adhesion was absent when unstimulated
cells or BSA-coated beads were used (data not shown).
Discussion
The understanding of the mechanism by which fibronectin can modulate mast
cell degranulation is potentially useful for the development of future therapy
against allergy and therefore topic of our investigations. Detailed study of this
phenomenon requires a mast cell model of which adhesion and degranulation
can be controlled independently, and in this report the protocols for such a
model are presented.
Our data showed that adhesion of BMMC to fibronectin can be modulated by
divalent cations. Consistently with other studies, adhesion is induced by Mn2+
and is antagonized by Ca2+ probably through modulation of the VLA-5
conformation7,116.
It has been shown previously that VLA-4, another fibronectin-binding integrin, is
also expressed on BMMC, however the role for this integrin in adhesion of
BMMC to fibronectin decreases during ontogeny and its function is taken over
gradually by VLA-5 45. In 4-6 weeks old BMMC that we use in our experiments,
adhesion to fibronectin is completely VLA-5-mediated. This conclusion is
confirmed by our data showing that blocking of VLA-5 function by either soluble
RGD or blocking Ab almost completely inhibits adhesion of BMMC to
fibronectin.
Binding to immobilized fibronectin induces integrin clustering, tyrosine
phosphorylation and eventually cytoskeleton rearrangement and focal adhesion
formation. These events are crucial for proper integrin-mediated cell
adhesion22,33,100. Our observation that Mn2+-induced adhesion is temperature-
sensitive is a strong indication that this adhesion can not simply be explained as
a cation-stabilized complexation of two proteins, VLA-5 and fibronectin, but
involves cellular signaling by enzymes. In addition, we show that inhibition of
tyrosine phosphorylation and dephosphorylation which are both needed for
proper integrin signaling58,75, attenuates Mn2+-induced adhesion of our cells to
fibronectin.
Consistently with other reports, Ca2+attenuates Mn2+-induced VLA-5-mediated
adhesion of BMMC to fibronectin. However, our data show that Ca2+ can only
prevent the induction of adhesion while the adhesion of cells already connected
to fibronectin, remains unaffected. This suggests that adhesion of BMMC to
fibronectin, induced by our protocol, can be divided into two stages as was
recently suggested 54. During the first stage, binding of Mn2+ to the cation
binding domain of VLA-5 induces a conformational change and thereby high-
affinity state of this integrin for fibronectin. During the second stage the binding
of VLA-5 with fibronectin results in ligand-mediated integrin clustering and
initiation of cellular signaling, strengthening the cell-substrate link through
formation of focal contacts and cytoskeleton rearrangement22,28,33. This stage
could be referred to as the outside-in signaling stage and is insensitive to Ca2+.
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The observation that BMMC adhered to fibronectin are unaffected by
extracellular Ca2+, indicates that our model is suitable for the investigation of the
modulation of FcεRI-induced degranulation that depends on influx of
extracellular calcium11.
One could argue that Mn2+ might directly influence the FcεRI signaling cascade
by interfering with Ca2+ signaling. However in our experiments we never
observed a significant effect of 0.2 mM MnCl2 on FcεRI-induced degranulation
(data not shown). Moreover, in our experiments all cells are treated with Mn2+
before exposure to either fibronectin or BSA, and any observed effect is
therefore substrate-specific.
The use of a horizontal surface, such as the bottom of a well, as carrier for
immobilized fibronectin has some disadvantages. First, for biochemical analysis
of this model, a larger amount of cells and therefore larger substrate area for
adhesion is needed. Secondly, variation in vertical position of the cells and
thereby variation in distance towards the substrate (bottom of the well),
introduces heterogeneity in the starting point of adhesion among the cells. To
prevent this, synchronization of adhesion by 30 minutes incubation on ice for
cell sedimentation is applied. Low temperature rarely is beneficial for biological
systems and should therefore, if possible, be prevented. Use of beads as carrier
for immobilized fibronectin26,95,112, provides a solution for the above mentioned
problems. The large area-to-volume ratio of beads enables us to work in smaller
volumes than when using a 2-dimensional carrier, and also enables us to mix
cells with fibronectin-coated beads so that adhesion of all cells is initiated at the
same time. We deliberately chose beads of which the size is equal to or higher
then that of the cells because it has been shown that smaller beads are subject
to phagocytosis instead of being an immobilizer of cells125.
In conclusion, in this report we introduce a novel model to study modulation of
mast cell degranulation through adhesion to fibronectin. We designed a protocol
using BMMC of which adhesion to fibronectin can be controlled. FcεRI-induced
degranulation of adhered BMMC can be studied under the normal conditions
needed for this cell function. By using polystyrene beads as carrier for
immobilized fibronectin, all steps of the protocol can be performed at a
physiological temperature and besides degranulation, analysis of the function of
adhered mast cells can be extrapolated to biochemical methods.
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Abstract
Release of allergic mediators from mast cells is enhanced by very late antigen-5
(VLA-5)-mediated interaction of these cells with fibronectin. The extracellular
part of the VLA-5 α-subunit was previously shown to contain a cation-binding
domain, homologous to the EF-hand of calmodulin, which is important for its
function. In this report we show that VLA-5-mediated adhesion of bone marrow-
derived mast cells can be induced by two different pathways, first by FcεRI-
clustering, which dependents on calmodulin activation and extracellular Ca2+,
and second by Mn2+ stimulation, independent of calmodulin activation and
antagonized by Ca2+. To show a role for EF-hands from different proteins in
VLA-5-mediated adhesion we used calcium-like peptides (CALP)1 and CALP2,
designed to bind to EF-hands based on inverted hydropathy. CALP1 and more
potently CALP2 inhibited FcεRI-induced calmodulin-dependent adhesion to
fibronectin, in correlation with their affinity for the calmodulin-EF-hand.
Interestingly only CALP2 was able to inhibit Mn2+-induced calmodulin-
independent adhesion by interfering with an extracellular target, probably VLA-
5. We conclude that CALP1 and 2 can inhibit VLA-5-mediated adhesion of mast
cells to fibronectin through binding to EF-hands of multiple proteins, and that
these peptides can be used as lead compounds for the development of future
therapy against allergy.
 Calcium-like peptides attenuate VLA-5 function
49
Introduction
Integrins are a family of heterodimeric cell surface receptors that bind
extracellular matrix and cell surface ligands and play a major role in various
processes such as inflammation, cell adhesion, migration, proliferation and
differentiation139. One example is the modulation of mast cell sensitivity for
antigenic stimulation through α5β1 integrin very late antigen-5 (VLA-5)i-mediated
interaction with the extracellular matrix-component fibronectin62,94,131. Antigenic
stimulation of mast cells by crosslinking of the high-affinity IgE receptor (FcεRI)
leads to release of various mediators which cause clinical phenomena
associated with an allergic response138,147. The observation that VLA-5 can
modulate mast cell degranulation makes this receptor a possible target for
future therapeutic strategies against allergy and is the topic of the current study.
Integrin ligand-affinity is modulated by a poorly understood mechanism, referred
to as inside-out signaling, whereby these receptors are converted from a low- to
high-affinity state44,74,93. It has been reported that the affinity of VLA-5 for
fibronectin can be modulated by cations. Mn2+ induces high-affinity of VLA-5 for
the Arginine-Glycine-Aspartic acid (RGD) sequence in fibronectin through
binding to the cation-binding motif in the extracellular domain of the VLA-5 α-
subunit. This effect can be antagonized by Ca2+ 116,118. The cation-binding motif
of VLA-5 is highly homologous to the Ca2+ binding EF-hand motif of calmodulin
(CaM)160. An EF-hand loop is formed by thirteen amino acids of which five play a
role in coordinating the binding of Ca2+ by means of their negatively charged
side chain. In the EF-hand-like motif of VLA-5, one of the coordinating amino
acids is replaced by an uncharged, nonfunctional, residue and it has been
postulated that its coordinating function is taken over by the negatively charged
side chain of aspartic acid of the RGD ligand sequence. In this view, high-
affinity binding is the result of cooperative coordination of the cation by the
integrin and the ligand and stabilization of this complex by the cation itself 7.
In addition to cations, it was recently shown that clustering of FcεRI triggers
VLA-5-mediated adhesion of murine bone marrow-derived mast cells (BMMC)
to fibronectin87,175. Although it has been established that influx of Ca2+ 11 and
CaM activation25,168 play a role in the FcεRI signaling cascade leading to
degranulation, it is unclear whether they play a role in the FcεRI-induced VLA-5
affinity modulation.
Accumulating evidence suggests that the gross architecture of a peptide or
protein is, at least in part, determined by its pattern of hydropathy and that exact
inversion of this pattern will result in a second peptide with a complementary
surface contour to the first because the hydrophobic effect is involved in
reversed orientation (reviewed by Blalock19). Supporting this theory, CALP1 (for
calcium-like peptide 1) designed as an amino acid sequence complementary to
that encoding a primordial EF-hand, was shown to mimic Ca2+ inducing CaM
activity, binding EDTA, inducing smooth muscle contraction38 and blocking Ca2+
influx through binding to the EF-hands of Ca2+ channels or indirectly via
CALP/CaM interaction with such channels (Manion et al. submitted for
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publication)ii. Another complementary peptide, CALP2, was designed by
computer-assisted optimal inversion of the hydropathy pattern of the EF-hand 4
amino acid sequence of CaM43,102,165. Due to increased length and optimal
hydropathy inversion, the affinity of CALP2 for the EF-hand compared to CALP1
was increased 11-fold as determined by surface plasmon resonance detection.
Interestingly, increased affinity by increased reciprocity of the pattern of
hydropathy and increased length of the peptide resulted in a change of
functional activity. Whereas CALP1 shows biological effects similar to Ca2+,
CALP2 acts as an antagonist for CaM165.
Influx of Ca2+ and subsequent CaM activation play a possible role in FcεRI-
induced affinity modulation of VLA-5 for fibronectin. In combination with the
assumption that based on the pattern of hydropathy the EF-hand-like domain of
VLA-5 is a potential binding site for CALP1 and CALP2, this suggests several
possible targets for these peptides to interfere with mast cell adhesion. In this
report we investigate the ability of CALP1 and CALP2 to inhibit VLA-5-mediated
adhesion of BMMC to fibronectin induced either by cationic stimulation or FcεRI
clustering.
Materials & Methods
Cells
BMMC were obtained as described previously84. Briefly, bone marrow from femurs of
Balb/c mice was flushed and cells were cultured at a density of 2 x 105/ml in complete
RPMI (RPMI1640 medium containing 4 mM L-glutamine, 5 x 10-5 M β-mercaptoethanol,
1mM sodium pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.1 mM
nonessential amino acids) supplemented with 20% (vol/vol) supernatant from Balb/c
splenocytes which were stimulated for 7-days with pokeweed mitogen (Sigma Aldrich
NV/SA, Axel, The Netherlands) in complete RPMI. Medium was refreshed once per
week. In all graphs mean ± s.e.m. of quadruplicates of a representative experiment are
shown.
Design and synthesis of the hydropathically complementary peptides
The design of the eight residue complementary peptide CALP1 (VAITVLVK) was based
on the primordial CaM EF hand 4 motif. Selection of the complementary peptide
CALP2 (VKFGVGFKVMVF) was carried out using the computer program AMINOMAT®
(Tecnogen ScpA, Italy), with an averaging window r=9, a range of inverted hydropathy
of 0.8 and considering also eight amino acids of the flanking regions. The program
generated 1,417,176 possible sequences, and chose the one with the lowest Q value
(0.0068). This value is defined by the formula: Q= [(ai+bi)2/(n-2s)]1/2, where ai
represents the moving averaged hydropathy assigned to every amino acid of the target
peptide, bi represents the moving averaged hydropathy assigned to every amino acid
of each of the complementary peptides generated by the program, s is (r-1)/2 (where r
is the number of amino acids considered in the moving window) and n is the number of
residues in the target peptide.
The peptides were synthesized using continuous flow solid phase peptide synthesis
with Fmoc chemistry, on a PerSeptive Biosystems 9050 Peptide synthesizer. Pre-
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activated Opfp amino acids with HoAt and preloaded PEG-PS resin were used. The
peptides were purified by RP-HPLC on a Waters Delta Pack C18 300 A (300 x 39 mm
I.D.). The purity of the product was checked by RP-HPLC on a Dynamax C18 (300 x
4.8 mm I.D.) column equilibrated at a flow rate of 1 ml/min and eluted with a linear
gradient from 5 to 80% CH3CN containing 0.1% TFA, in 40 min. MilliQ water previously
treated with Chelex 100 to remove any Ca2+ was used in the purification. The identity of
the peptides was confirmed by TOF-MALDI MS (U.A.B. Core Facility).
Adhesion assay
For Mn2+-induced adhesion, 4-6 weeks old BMMC were washed with PBS, 1 mM EDTA
in PBS and Tris-buffered saline (TBS, 2.9 g/L Tris-Cl, 4 g/L NaCl, 0.2 g/L KCl, 0.4 g/L
glucose, 0.1 % BSA) and resuspended at a density of 5 x 105 cells/ml TBS. For FcεRI-
mediated adhesion, 4-6 week old BMMC were incubated 1 hr at 37°C in complete
RPMI supplemented with supernatant of the anti-DNP IgE producing hybridoma,
26.8298, washed as described above, and cells were resuspended in TBS with or
without 1.8 mM CaCl2 as indicated, at a density of 5 x 105 cells/ml. NUNC maxisorp 96
wells plates were coated for 3 hrs at 37°C with 200 µl/well 2.5 mg/ml human fibronectin
(CLB, Amsterdam) in PBS, followed by 3 times washing with 200 µl/well PBS. 100 µl
cells per well were incubated with 50µl of Mn2+ as indicated or 50 µl of DNP-HSA (final
concentration: 3 µg/ml, or as indicated, Sigma Aldrich NV/SA, Axel, The Netherlands),
and 50 µl of CALP or W7 (Sanvertech B.V., Heerhugowaard, The Netherlands) (final
concentrations as indicated in graphs). CALP2-biotin (2 x 10-4 M) was preincubated
with or without streptavidin (SA, 1 x 10-4 M, Boehringer Mannheim B.V.) in TBS for 1 hr
at room temperature under constant rotation, before application to the cells. Cells were
incubated on a fibronectin-coated plate at 37°C and after 60 minutes non-adhered cells
were removed by three times washing with 200 µl/well PBS. For functional blocking of
VLA-5, cells were incubated with blocking antibody BMA5 (a generous gift from Dr.
B.M.C. Chan, Univ. Western Ontario, Canada)45, one hour before at room temperature,
or various concentrations of RGD peptide (Sigma Aldrich NV/SA, Axel, The
Netherlands) during incubation on fibronectin. Adhesion was quantified using Cyquant
proliferation assay kit (Molecular Probes Europe B.V., Leiden, The Netherlands)
according to the manufacturer’s protocol. In short, plates were frozen overnight at –
20°C, thawed and incubated for 60 minutes under continuous agitation at room
temperature with a DNA-specific fluorescent dye and lysing reagent. Fluorescence was
measured at λex.: 485 nm / λem.: 530 nm using a Millipore Cytofluor 2350 microplate
reader and adhesion was calculated as the residual fluorescence as a percentage of
input fluorescence. In all graphs mean ± s.e.m. of quadruplicates of a representative
experiment are shown.
Degranulation assay
4-6 Weeks old BMMC were sensitized with anti-DNP IgE as described above, washed
and resuspended at 5 x 105 cells/ml in Tyrode’s buffer (Life Technologies B.V., Breda,
The Netherlands) supplemented with 10 mM HEPES, 1 g/L NaHCO3, 0.1 % BSA, pH
7.2). 100 µl of cells per well of a Costar 96 well plate were incubated with 50 µl of DNP-
HSA (final concentration: 30 ng/ml) and 50 µl of CALP or with CALP alone as indicated,
for 30 minutes at 37°C. Supernatants were analyzed for β-hexosaminidase content as
parameter for mast cell degranulation as described previously84. In short, 50 µl of
supernatant was incubated for 60 minutes at 37°C with 50 µl 4-methylumbelliferyl-N-
acetyl-β-D-glucosaminide (Sigma Aldrich NV/SA, Axel, The Netherlands) in citrate
buffer (0.1 M, pH 4.5), the reaction was stopped by addition of 100 µl of glycine buffer
(0.2 M glycine, 0.2 M NaCl, pH 10.7) and fluorescence was measured at λex.:
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360nm/λem.:460nm using a Millipore Cytofluor 2350 microplate reader. Degranulation
was calculated as the amount of β-hexosaminidase activity present in the supernatant
as a percentage of the total β-hexosaminidase activity present in the cells, determined
in lysates of 5 x 104 cells. In all graphs mean ± s.e.m. of quadruplicates of a
representative experiment are shown.
Results
Cationic modulation of BMMC adhesion to fibronectin
To investigate if the previously reported cation-mediated modulation of VLA-5
affinity for fibronectin116 can be extrapolated to BMMC, extracellular Ca2+ was
removed by EDTA treatment and cells were incubated with various
concentrations of MnCl2 on immobilized fibronectin. As is shown in figure 1A,
MnCl2 dose-dependently induces the adhesion of BMMC to fibronectin. Optimal
adhesion of approximately 75% of cells is reached at 0.2 mM MnCl2, and this
concentration was used in all subsequent experiments. To investigate if Ca2+
can antagonize Mn2+-induced adhesion, cells were treated with EDTA and
incubated on immobilized fibronectin with MnCl2 and various concentrations of
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Figure 1 Adhesion of BMMC to fibronectin.
BMMC were treated with EDTA to remove
extracellular Ca2+ and incubated with (A)
various concentrations of MnCl2 or (B) 0.2
mM MnCl2 and various concentrations of
CaCl2 at 37°C on a fibronectin coated 96
wells plate. (C) Cells, prepared for Mn2+-
induced adhesion, were incubated with 15
µg/ml BMA5 one our at room temperature
before or various concentrations of RGD
peptide during the incubation on fibronectin.
After 60 minutes non-adhered cells were
removed by washing and adhesion was
quantified
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CaCl2. Figure 1B shows that CaCl2 dose-dependently reduces MnCl2-induced
adhesion. Previous data showing that adhesion of BMMC to fibronectin is VLA-
5-mediated were confirmed by almost complete inhibition of Mn2+-induced
adhesion of our cells to fibronectin by soluble ligand, RGD peptide, and blocking
antibody BMA5 as is shown in figure 1C. From these data we conclude that in
BMMC, the regulation of adhesion to fibronectin by cations parallels earlier
published data reporting that Mn2+ induces a conformational change of VLA-5 to
high-affinity for fibronectin, via a mechanism that is antagonized by Ca2+.
A role for extracellular Ca2+ in FcεRI-induced adhesion of BMMC to
fibronectin
To investigate if the presence of extracellular Ca2+ is necessary for the induction
of adhesion by FcεRI clustering, anti-DNP IgE sensitized BMMC were treated
with EDTA and stimulated with DNP-HSA on immobilized fibronectin in CaCl2-
supplemented buffer (final concentration: 1.8 mM) or calcium-free buffer. As is
shown in figure 2, stimulation of BMMC via FcεRI dose-dependently induces
adhesion to fibronectin in buffer supplemented with Ca2+, however the absence
of this divalent cation completely abrogates FcεRI-induced adhesion of these
cells. From these results we conclude that in addition to FcεRI-induced mast
cell degranulation, the presence of extracellular Ca2+ is critical for the FcεRI
signaling cascade that induces adhesion of BMMC to fibronectin.
A role for CaM in FcεRI- or Mn2+-induced adhesion
To study whether CaM plays a role in antigenic or cationic modulation of VLA-5
affinity for fibronectin, we investigated the effect of the CaM inhibitor, W7, on the
adhesion induced by either FcεRI clustering or Mn2+ stimulation. Anti-DNP IgE
sensitized cells were stimulated with DNP-HSA and EDTA-treated cells were
stimulated with Mn2+ on immobilized fibronectin with various concentrations of
W7. As is shown in figure 3, W7 inhibits adhesion of FcεRI-stimulated BMMC,
however it has no effect on adhesion of cells stimulated with MnCl2. From these
data we conclude that adhesion of BMMC to fibronectin due to modulation of
VLA-5 affinity by either FcεRI clustering or Mn2+ stimulation is mediated via
distinct signaling pathways that are CaM-dependent and –independent,
respectively.
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Figure 2 FcεRI-induced adhesion of BMMC
to fibronectin in absence and presence of
extracellular Ca2+. Anti-DNP IgE-sensitized
BMMC were treated with EDTA to remove
extracellular Ca2+ and resuspended in buffer
without (no Ca2+) or with (Ca2+) CaCl2 (final
concentration: 1.8 mM). Cells were incubated
with 0.3 ng/ml DNP-HSA at 37°C on a
fibronectin coated 96 wells plate. After 60
minutes non-adhered cells were removed by
washing and adhesion was quantified. (Error
bars are covered by symbols used)
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The effect of CALP1 and CALP2 on FcεRI and Mn2+-induced adhesion of
BMMC to fibronectin
Our data indicate that FcεRI signaling leading to adhesion is Ca2+ and CaM
dependent and therefore an effect of both CALP1 and 2 on FcεRI-induced
adhesion can be expected. Anti-DNP IgE sensitized BMMC were stimulated
with DNP-HSA in the presence of various concentrations of either CALP1 or
CALP2 on immobilized fibronectin. Indeed, as is shown in figure 4A, we find that
both CALP1 and CALP2 are able to dose-dependently inhibit adhesion induced
by FcεRI clustering. We observed that CALP2 is a more potent inhibitor than
CALP1 (EC50= 3.5 x 10-5 and 1 x 10-4 M respectively) and that both peptides fail
to induce adhesion of our cells to fibronectin (data not shown).
The observation that Mn2+-induced adhesion of BMMC to fibronectin is
mediated via a Ca2+- and CaM–independent pathway provides us with the
opportunity to investigate if CALP1 and CALP2 are able to interfere with
adhesion through binding to a target other than the CaM EF-hand. EDTA-
treated BMMC were stimulated with Mn2+ and various concentrations of either
CALP1 or CALP2 on immobilized fibronectin. As is shown in figure 4B, CALP1
does not have an effect on Mn2+-induced adhesion, however CALP2 dose-
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Figure 3 Effect of CaM inhibitor W7 on
cation- and antigen-induced adhesion of
BMMC to fibronectin. Anti-DNP IgE
sensitized mast cells were stimulated with 3
ng/ml DNP-HSA in CaCl2-supplemented
buffer (closed circles), or 0.2 mM MnCl2 in
calcium-free buffer (open circles) and
incubated with various concentrations of W7
at 37°C on a fibronectin coated 96 wells plate
(96W). After 60 minutes non-adhered cells
were removed by washing and adhesion was
quantified. In several cases error bars are
covered by symbols
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Figure 4. Effect of CALP1 and CALP2 on FcεRI- and Mn2+-induced adhesion of BMMC to
fibronectin. BMMC were stimulated (A) via clustering of FcεRI or (B) with Mn2+ and incubated
with various concentrations of CALP1(closed circles) or CALP2 (open circles) on immobilized
fibronectin. After 60 minutes non-adhered cells were removed by washing and adhesion was
quantified.
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dependently inhibits Mn2+-induced adhesion of our cells to fibronectin,
suggesting a target for CALP2 other than CaM because this pathway is CaM-
independent.
Effect of prevention of CALP2 cell entry on its ability to inhibit adhesion
Our data show that CALP 2, as well as CALP1, are able to inhibit the Ca2+- and
CaM-dependent adhesion, suggesting an intracellular target for these peptides.
Only CALP2 is able to attenuate Ca2+- and CaM-independent adhesion, and we
suggest that the target for CALP2 is the EF-hand-like domain of VLA-5 which is
located extracellularly.
To test for an extra- versus intracellular “non-CaM” target, CALP2 was labeled
with N-terminal biotin. This peptide was incubated and complexed with SA to
prevent it from entering the cells, and to specifically target extracellular sites.
BMMC were stimulated on immobilized fibronectin either via FcεRI or with Mn2+
together with free or complexed CALP2-biotin. Figure 5 shows that prevention
of cell entry largely abrogates the inhibiting effect of CALP2 on FcεRI-induced
adhesion, while the inhibiting effect of this peptide on Mn2+-induced adhesion of
BMMC to fibronectin is largely retained. These data show that besides the
ability of CALP2 to inhibit adhesion through binding to intracellular targets such
as CaM, this peptide can also attenuate adhesion of BMMC to fibronectin by
way of binding to extracellular targets.
Effect of CALP1 and CALP2 on mast cell degranulation
Our data show that both CALP1 and 2 inhibit FcεRI-induced adhesion of BMMC
to fibronectin, which suggest that that these peptides interfere with Ca2+-influx
and/or CaM activation. To investigate this, we tested the effects of these
peptides on FcεRI-degranulation, a mast cell parameter which has been shown
to be dependent on Ca2+-influx and CaM activation, which should be
comparable to those on FcεRI-induced adhesion. Anti-DNP IgE sensitized
BMMC were stimulated with DNP-HSA in the presence of various
concentrations of CALP1 or CALP2 and the release of granular β-
hexosaminidase, as a measure for degranulation, was determined. As is shown
in figure 6A, CALP1 and more potently CALP2, parallel to adhesion, dose-
dependently inhibited β-hexosaminidase release from BMMC (EC50: 2 x 10-5
Figure 5. Effect of prevention of cell entry
of CALP2 on its adhesion inhibiting
potency. BMMC were stimulated via
clustering of FcεRI or with Mn2+ and
incubated with free CALP2-biotin (no SA) or
with CALP2-biotin complexed with
streptavidin (SA) on immobilized fibronectin.
After 60 minutes non-adhered cells were
removed by washing and adhesion was
quantified.
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and. 6 x 10-6 M respectively). Both peptides lacked the intrinsic ability to induce
mast cell degranulation, as is shown in figure 6B. From these data we conclude
that CALP1 and 2 both attenuate FcεRI-induced degranulation by interfering
with the same targets as those in FcεRI-induced adhesion, probably Ca2+-influx
and CaM activation.
Discussion
The observation that VLA-5 can modulate mast cell degranulation makes this
receptor a possible target for future therapeutic strategies against allergy. Our
data show that high-affinity of VLA-5 and subsequent adhesion of BMMC to
fibronectin can be induced via two separate pathways, first by clustering of
FcεRI, which is dependent on activation of CaM and extracellular Ca2, and
second by Mn2+-stimulation which is independent of CaM and even antagonized
by Ca2+.
Because FcεRI-induced adhesion as well as degranulation are both dependent
on extracellular Ca2+ and activation of CaM, it is logical to assume that both are
mediated by the same signaling cascade and therefore affected similarly by
CALP1 and 2. Inhibition by CALP2 seemed predictable as this peptide was
shown to be an antagonist for CaM activation165 and should therefore have the
same affect as the CaM inhibitor, W7. Inhibition of adhesion and degranulation
by CALP1 can not be explained by inhibition of CaM, since it was shown that
this peptide mimics Ca2+ by activating CaM38,165. Importantly, it was shown
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Figure 6. Effect of CALP1 and 2 on degranulation of BMMC. (A) Anti-DNP IgE sensitized
BMMC were incubated with various concentrations of CALP1 (closed circles) or CALP2 (open
circles) for 30 minutes at 37°C. Additionally, cells were stimulated with 30 ng/ml DNP-HSA (A)
or not (B), and after 30 minutes β-hexosaminidase release as a measure for degranulation was
quantified. The bar in figure 6 B represents degranulation of these cells triggered with 30 ng/ml
DNP-HSA in the absence of CALPs, as control for their function. (In several cases error bars
are covered by symbols used)
A B
10-3 10-2 10-1 100
0
50
100
150 CALP1
CALP2
[CALP] (mM)
%
 in
hi
bi
tio
n
 Calcium-like peptides attenuate VLA-5 function
57
recently that CALP1 not only mimics Ca2+ in its binding and activating
characteristics towards CaM, but is also able to directly, as well as indirectly,
through CaM, block the N-methyl-D-aspartate type calcium channel of rat
neuronal cells and the nonselective cation channel (NSCC) of Jurkatt cells
which provide negative feedback for Ca2+ influx (Manion et al. Submitted for
publication) Thes channels were shown to be present in mast cells and play a
role in mast cell degranulation72,73,129,130 and these receptors could serve as
targets for CALP1 in our cells. The closure of cation channels also explains the
lack of intrinsic ability of CALP1 to induce degranulation, which is characteristic
of Ca2+ ionophores15. Of CALP1 and CALP2 the latter was the most potent
inhibitor of both adhesion and degranulation which can be explained by the fact
that this peptide has the higher affinity for the CaM EF-hand.
The EC50 of both peptides for inhibition of adhesion was approximately fivefold
higher than that for inhibition of degranulation. In our experiments we find that
the amount of allergen needed for optimal degranulation is approximately
tenfold higher than that for optimal adhesion (unpublished observations), this
suggest that a stronger FcεRI signal is needed for degranulation and is
therefore more sensitive to the inhibiting effects of CALP1 and 2.
Mn2+-induced adhesion is independent of CaM activation and an inhibiting
effects of any CALP on adhesion is, therefore, mediated by different targets
than those described for the FcεRI pathway. We find that CALP2 but not CALP1
is able to inhibit Mn2+-induced adhesion of BMMC to fibronectin, which could be
explained by the higher affinity of this peptide for EF-hands. The EC50 of CALP2
for inhibition of Mn2+-induced adhesion is approximately threefold higher than
that for inhibition of FcεRI-induced adhesion. This suggests either lower affinity
of CALP2 for this EF-hand than for CaM, or a higher quantity of EF-hands that
need to be bound for a comparable effect. We claim that the target for CALP2 in
the inhibition of Mn2+-induced adhesion is the EF-hand-like domain of VLA-5,
and because this motif has a hydropathy profile identical to the CaM EF-hand, it
should therefore bind CALP2 with the same affinity. Therefore we propose that
the difference in target quantity is the explanation for this observation.
In our experiments using SA-complexed CALP2, a partial inhibition of FcεRI-
induced adhesion can be observed. There are several explanations for this
phenomenon. First, the presence of some unbound CALP-2-biotin could
attenuate CaM activation, we show that an effect of CALP2 on IgE-mediated
degranulation could already be observed at low concentrations. Second, there
could be a direct effect of CALP2 on the EF-hand like domain of VLA-5 in
FcεRI-induced adhesion. In the same experiment we also observed a partial
attenuation of the inhibiting capacity of complexed CALP2 compared to free
CALP2. This could be explained by the fact that the binding of CALP2 to the
EF-hand like domain of VLA-5 is partially interfered spherically by the bulky SA-
molecule to which it is bound.
Although we have no data showing direct interaction between VLA-5 and
CALP2, several arguments support our conclusion that this integrin is targeted
during inhibition of CaM independent adhesion. First, based on hydropathy and
sequence homology to CaM EF-hands the EF-hand-like domain of VLA-5 forms
a potential binding site for CALP2. Second, the affinity of CALP2 and Ca2+ for
CaM was shown to be comparable34,165. Accordingly, we find that the EC50 of
these agents for inhibition of Mn2+-induced adhesion is also comparable. Third,
although EF-hand motifs are present in numerous proteins that play a role in
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various cellular processes163, most of these are localized intracellularly. The
observation that our target is located extracellularly, narrows the list of possible
candidates drastically and mainly leaves us with the integrins. We and others
have shown that in 4-6 weeks old BMMC, adhesion to fibronectin is entirely
VLA-5-mediated45,87, which strongly suggests this integrin as the most obvious
candidate.
There are several mechanisms by which CALP2 could inhibit VLA-5 binding to
fibronectin. Binding of the peptide to the VLA-5 EF-hand-like domain could
induce a conformational change of the integrin to a low-affinity state, a
mechanism which was also postulated for the antagonizing effect of Ca2+ in
cation modulation of VLA-5 affinity116,118. Although it was shown that EF-hand-
binding to troponin C of CALP2 induces a conformational change of this protein,
this conformational change was different from the one induced by Ca2+ 165.
Another possible mechanism is that due to binding to the EF-hand-like domain,
which is localized in the ligand-binding site of the integrin, binding of the ligand
by the integrin is physically blocked and thereby adhesion is prevented.
Previous studies have shown that hydropathic patterning can be used to tailor
make peptide ligands targeted to the EF-hand of CaM and that by increasing
affinity the functional activity of the peptide can be modulated from agonistic to
antagonistic38,165. In this report we show that these peptides can be applied to
block cell adhesion by interfering with CaM and other targets, presumably the
EF-hand-like domain of VLA-5. Their ability to block adhesion and thereby
modulate the activity of mast cells indicates that these peptides could serve as
possible lead compounds for the development of future therapies against
allergy and other pathologies in which proteins with EF-hands are involved.
Cation-induced adhesion of bone marrow-derived
mast cells to fibronectin induces degranulation in
vitro and in vivo
René Houtman, Aletta D. Kraneveld, Andries S. Koster and
Frans P. Nijkamp
(Submitted for publication)
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Abstract
Previously, it was demonstrated that degranulation of RBL-2H3 mast cells is
enhanced by α5β1 integrin very late antigen-5 (VLA-5)-mediated adhesion to
fibronectin. However, RBL-2H3 cells adhere nonspecifically to various
substrates, and we therefore used mast cells cultured from mouse bone marrow
(BMMC) to investigate the effect of adhesion to fibronectin on degranulation. It
has been demonstrated previously that Mn2+ induces a conformational change
of VLA-5 into high-affinity for fibronectin. In our experiments, Mn2+-induced
adhesion to fibronectin enhanced allergen-induced mast cell degranulation in
vitro. Surprisingly, adhesion to fibronectin induced by Mn2+ but also by Zn2+,
Ni2+, and Co2+, metals that are known to induce contact hypersensitivity
responses, directly triggered mast cell degranulation in vitro in absence of an
antigenic stimulus. This effect could be blocked by soluble arginin-glycine-
aspartic acid (RGD) confirming a role for VLA-5. In addition, local injection of
BMMC stimulated in vitro with Mn2+, into the skin of BALB/c mice resulted in
spontaneous activation and enhanced allergen-induced activation of these cells
in vivo. This response was also attenuated with soluble RGD peptide. In
conclusion, our data show that VLA-5 can modulate mast cell sensitivity for
antigenic stimulation and provide a plausible explanation for hypersensitivity
responses to various metals in which cation-induced integrin-mediated
adhesion directly triggers degranulation.
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Introduction
Mast cells are localized in all vascularized tissues and play an important role in
hypersensitivity type I responses147. Crosslinking of the high-affinity receptor for
IgE (FcεRI)i on mast cells triggers a signal transduction cascade leading to the
release of various inflammatory mediators, which cause clinical phenomena
associated with allergy12,14,59. An increasing number of reports suggest that the
function of the mast cell is affected by its microenvironment, consisting of
neighboring cells, extracellular matrix and various humoral factors, probably by
modulating the FcεRI signal transduction cascade39,56,134,155. Adhesion to the
extracellular matrix component fibronectin has been shown to enhance FcεRI-
induced degranulation of RBL-2H3 mast cells62,64,131,155. Although it was shown
that this adhesion is mediated by the α5β1-integrin very late antigen-5 (VLA-5)
and the arginine-glycine-aspartic acid (RGD) sequence of fibronectin150,177, the
mechanism by which FcεRI signaling is influenced is not yet understood.
Elucidation of the molecular basis of the role for VLA-5 in mast cell
degranulation, which is potentially useful for the development of future therapy
against allergy, is therefore topic of our research.
A model system was required in which adhesion and degranulation can be
independently controlled. RBL-2H3 cells, a widely used model for mast cells,
adhere to various surfaces without assembling specialized adhesion structures
at the cell-substrate interface8,124, and are therefore not suitable to study the
effect of adhesion on degranulation. We used mast cells cultured from mouse
bone marrow (BMMC)84,133, because these cells do not show nonspecific
adhesion. Although it has been shown that VLA-5 is expressed on BMMC45,177,
these cells do not adhere spontaneously to fibronectin. Importantly, it has been
demonstrated that on resting cells integrins exist in a low-affinity conformation
and that cell activation triggers the conversion of these receptors into a high-
affinity state via a mechanism referred to as inside-out signaling44,46,55,74,93.
Accordingly, it was shown that stimulation of BMMC by PMA induces VLA-5-
mediated adhesion to fibronectin, via a phosphatidylinositol 3-kinase-dependent
pathway87.
The affinity of VLA-5 for fibronectin is also modulated directly by cations, as was
demonstrated in K562 erythroleukemia cells116,118. The extracellular domain of
the VLA-5 α-subunit contains several cation-binding motifs and binding of Mn2+
induces a conformational change of the integrin into high-affinity, a mechanism
which is antagonized by Ca2+. Additionally, integrin-ligand binding is stabilized
by the cooperative coordination and binding of Mn2+ by negatively charged
amino acid residues of the cation-binding domain localized in the ligand binding
area of VLA-5, and the negatively charged aspartic acid of the RGD-sequence
in fibronectin7. In this report we investigated the adhesion of BMMC to
fibronectin induced by various cations. In addition, the effect of VLA-5-mediated
adhesion on degranulation of BMMC were studied in vitro and in vivo.
                                                          
i For abbreviations see page 101
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Materials & Methods
Animals
Male BALB/c mice (6-8 week, Central Animal Laboratory (GDL), Utrecht University,
Utrecht, The Netherlands) were used in all experiments. The experiments were
approved by the Animal Care Committee, Utrecht University.
Cells
BMMC were obtained as described previously
84
. Briefly, bone marrow from femurs of
BALB/c mice was flushed and cells were cultured at a density of 2 x 105/ml in complete
RPMI (RPMI1640 medium, 4 mM L-glutamine, 5 x 10-5 M β-mercaptoethanol, 1 mM
sodium pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.1 mM
nonessential amino acids) supplemented with 20 %(vol/vol) culture supernatant from 7-
day pokeweed mitogen (Sigma Aldrich NV/SA, Axel, The Netherlands)-stimulated
BALB/c splenocytes. Medium was refreshed once per week. For all experiments 4-6
weeks old BMMC were used.
Immobilization of fibronectin
NUNC maxisorp 96 well plates were incubated for 3 hours at 37°C with 2.5 mg/ml
human fibronectin (CLB, Amsterdam, The Netherlands) in Tris-buffered saline (TBS,
2.9 g/L Tris-Cl, 4 g/L NaCl, 0.2 g/L KCl, 0.4 g/L glucose, 0.1 % BSA), 200 µl/well,
washed 3 times with 200 µl/well PBS, and used for cell adhesion experiments.
Polystyrene beads (mean diameter 11.9 µm, Sigma Aldrich NV/SA, Axel, The
Netherlands) were incubated for 1 hour at room temperature with 2.5 mg/ml human
fibronectin (CLB, Amsterdam, The Netherlands) or in TBS containing 1% BSA (Sigma
Aldrich NV/SA, Axel, The Netherlands) as control for non-adhered cells, under constant
rotation, followed by three times washing with an excess volume of TBS and used for
mast cell degranulation experiments.
Preparation of the cells for degranulation and adhesion
Sensitization of BMMC was performed by incubation of the cells with culture
supernatant of hybridoma 26.82 containing anti-dinitrophenyl (DNP)-specific IgE98,
optimal concentration was empirically determined, data not shown) for 1 hour at 37°C.
Subsequently cells were washed once with PBS, once with 1 mM EDTA in PBS at
37°C, and once with TBS and resuspended in TBS for experimental use.
In vitro adhesion of BMMC
For adhesion to a fibronectin-coated 96 well plate, nonsensitized BMMC were prepared
as described , and 5 x 104 cells per well were incubated with 0.2 mM Mn2+, 3.0 mM
Zn2+, 3.0 mM Ni2+ or 2.0 mM Co2+ in TBS with or without 1 mg/ml soluble RGD (Sigma
Aldrich NV/SA, Axel, The Netherlands) for 30 minutes on ice to synchronize adhesion.
Subsequently, the 96 well plate was transferred to 37°C and after 30 minutes non-
adhered cells were removed by washing of the plate.
For adhesion to beads, BMMC were prepared as described, stimulated with 0.2 mM
Mn2+, 3.0 mM Zn2+, 3.0 mM Ni2+ or 2.0 mM Co2+ at a density of 7.5 x 106 cells/ml in TBS
with or without 1 mg/ml soluble RGD, mixed with a pellet of fibronectin- or BSA coated
beads (beads:cells ratio = 1:1) and centrifuged briefly to pellet the cell/bead mixture.
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The cell/bead pellet was incubated at 37°C for 5 minutes, gently resuspended and
incubated for an additional 25 minutes at 37°C.
Quantification of adhesion
Adhesion to fibronectin-coated 96 well plates, was quantified using Cyquant
proliferation assay kit (Molecular Probes Europe B.V., Leiden, The Netherlands)
according to the manufacturer’s protocol. In short, samples were frozen overnight at -
20°C, thawed and incubated for 60 minutes under continuous agitation at room
temperature with a DNA-specific fluorescent dye and lysing reagent. Fluorescence was
measured at λex.: 485nm/λem.: 530nm using a Millipore Cytofluor 2350 microplate
reader and adhesion was calculated as the residual fluorescence as percentage of
input fluorescence.
Quantification of in vitro mast cell degranulation
As parameter for in vitro mast cell degranulation, the release of granular β-
hexosaminidase was measured. Per volume of the BMMC/bead mixture, 14 volumes of
Tyrode’s buffer (0.1 M Tyrode salts: Life Technologies BV, Breda, The Netherlands;
100 mM HEPES/ 0.1 % NaHCO3, pH 7.2; supplemented with 0.1 % BSA) were added
to supplement extracellular Ca2+. Per sample, 5 x 104 cells of the cell/bead mixture
were stimulated with 0-100 ng/ml DNP-HSA (Sigma Aldrich NV/SA, Axel, The
Netherlands). After 30 minutes at 37°C, 50 µl of supernatant of each sample was
collected and samples of 5 x 104 unstimulated cells of each treatment-group were lyzed
using 0.1 % NP-40 (Omnilabo International, Breda, The Netherlands) in order to
quantify the total β-hexosaminidase activity present in these cells. Samples were
analyzed for β-hexosaminidase activity as described previously84. In short, samples
were incubated for 60 minutes with 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide
(4-MUG, Sigma Aldrich NV/SA, Axel, The Netherlands) and the reaction was stopped
with 0.2 M glycin buffer (pH 10.7). 4-MUG hydrolysis was determined by fluorimetric
measurement (λex: 360nm/λem: 452nm) using a Millipore Cytofluor 2350 microplate
reader. The percentage of β-hexosaminidase released, was calculated as
follows:100% x fluorescencesupernatant/fluorescencecell lysate corrected for the β-
hexosaminidase activity present in the supernatant of nonchallenged cells incubated
with BSA-coated beads, representing nonadhered cells.
Quantification of in vivo mast cell degranulation
As parameter for in vivo mast cell degranulation we measured plasma leakage induced
by a modified protocol for passive cutaneous anaphylaxis.
In vitro treatment of cells: BMMC were sensitized or not, prepared as described for in
vitro adhesion and incubated at a density of 2.5 x 106 cells/ml in suspension with 0.2
mM Mn2+, with or without 1 mg/ml soluble RGD, for 30 minutes at 37°C (see graph
legends).
Passive cutaneous anaphylaxis: 15 minutes before the start of the experiment, mice
were anaesthetized with sodium pentobarbitone (30 mg/kg, i.p.) and shaved dorsally.
At t = 0 minutes, in vitro treated BMMC (5 x 104 cells, 20 µl per patch) and Evans blue
dye (EB, 12.5 mg/ml, 50 µl, i.v.) were injected intradermally. The site of injection of
each sample of cells was varied between mice to exclude site-dependent effects. After
30 minutes DNP-HSA (20 mg/ml, 50 µl, i.v.) was injected and after additional 30
minutes mice were sacrificed. Circular skin patches (9 mm in diameter) were excised
and blood samples were taken. EB was extracted from skin samples by incubation in
0.5 ml formamid for 5 days at 50°C. The amount of EB in extracts and plasma samples
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was quantified by measuring the OD at 595 nm using a Biorad Benchmark Microplate
reader, corrected for its dilution in formamid, and extravasation was calculated resulting
in µl extravasated plasma per skin patch.
Statistical analysis
All data are expressed as mean ± SEM. Statistically significant differences were
determined using ANOVA followed by a Bonferroni post-hoc or Student’s t-test
considering p<0.05 to be significant. All analyses were performed using Systat for
Windows (version 6.1, SPSS Inc., 1996).
Results
Effect of adhesion to fibronectin on degranulation of BMMC
To investigate the effect of Mn2+-induced adhesion on degranulation, anti–DNP
IgE-sensitized BMMC were prepared for adhesion by removal of extracellular
Ca2+ with EDTA. Additionally cells were stimulated with 0.2 mM Mn2+ to convert
VLA-5 to high-affinity and incubated with fibronectin- or BSA-coated beads.
After 30 minutes, extracellular Ca2+was supplemented, cells were antigenically
challenged with various concentrations of DNP-HSA and β-hexosaminidase
release was determined. As is shown in figure 1A, incubation of BMMC with
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Figure 1. Effect of Mn2+-induced adhesion to fibronectin on degranulation of BMMC. Anti-
DNP IgE-sensitized BMMC were prepared for adhesion, stimulated with 0.2 mM Mn2+, incubated
with fibronectin (FN)- or BSA-coated polystyrene beads and after 30 minutes extracellular Ca2+
was supplemented (final concentration: 1.8 mM). Cells were challenged (A) with various
concentrations of DNP-HSA or (B) with buffer only. After 30 minutes β-hexosaminidase release
was measured. β-hexosaminidase release was corrected for the β-hexosaminidase content in
the supernatant of cation-stimulated nonchallenged BMMC incubated with BSA-coated beads.
Means ± SEM, n=4 of a representative experiment are shown, * p<0.05, by (A) ANOVA followed
by Bonferroni post hoc (B) Student’s t-test, compared to cells incubated with BSA-coated
beads.
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fibronectin-coated beads significantly enhances allergen-induced degranulation
of these cells compared to cells incubated with BSA-coated beads. Figure 1B
shows that adhesion of BMMC to fibronectin-coated beads itself significantly
induces β-hexosaminidase release of these cells even when an antigenic
stimulus is absent. From these data we conclude that adhesion of BMMC to
fibronectin not only enhances allergen-induced degranulation but also directly
triggers mast cell degranulation by an allergen-independent mechanism.
Effect of soluble RGD on adhesion-induced degranulation
VLA-5 plays a role in adhesion of BMMC to fibronectin and its function can be
blocked by soluble RGD peptide87. To assess a role for VLA-5 in our model, we
tested the effect of soluble RGD on adhesion-induced BMMC-activation.
Nonsensitized BMMC were prepared for adhesion as described, stimulated with
Mn2+ and incubated for 30 minutes with BSA-coated beads or with fibronectin-
coated beads with or without 1 mg/ml soluble RGD and β-hexosaminidase
release was determined. As is shown in figure 2, degranulation triggered by
Mn2+-induced adhesion to fibronectin can be completely blocked by soluble
RGD. Soluble RGD itself did not affect degranulation (data not shown) From
these data we conclude that degranulation triggered by adhesion to fibronectin
is mediated by VLA-5.
Cation-induced adhesion and degranulation of BMMC
Our data show that Mn2+ is able to induce adhesion of mast cells to fibronectin
and subsequently trigger degranulation. This raised the question if other cations
from metals that are known for their ability to induce allergic contact dermatitis,
such as zinc, nickel and cobalt have the potency to induce adhesion and
thereby evoke degranulation. BMMC were prepared for adhesion and incubated
with Mn2+ (0.2 mM) or Zn2+, Ni2+ or Co2+ (0.1-10 mM) on a fibronectin-coated 96
well plate, which allows us to remove nonadhered cells by washing and to
quantify adhesion. Figure 3 shows the adhesion of BMMC to fibronectin
triggered by the optimal concentration of each cation. Mn2+ (0.2 mM), Zn2+ (3
mM), Ni2+ (3mM) and Co2+ (1 mM) are able to significantly induce adhesion of
BMMC to fibronectin. Additionally, as shown in figure 3A, the adhesion induced
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adhesion-induced degranulation of BMMC.
BMMC were prepared for adhesion,
stimulated with 0.2 mM Mn2+ and incubated
for 30 minutes with BSA-coated polystyrene
beads (BSA) or with fibronectin-coated
polystyrene beads in the absence
(fibronectin) or presence (fibronectin+RGD)
of 1 mg/ml soluble RGD. Extracellular Ca2+
was supplemented and after 30 minutes β-
hexosaminidase release was measured.
Means ± SEM, n=4 of a representative
experiment are shown. * p<0.05 by Student’s
t-test, compared to cells incubated with BSA-
coated beads; # p<0.05 by Student’s t-test,
compared to cells incubated with fibronectin-
coated beads in the absence of soluble RGD.
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by each of these cations can be blocked by soluble RGD. This finding shows
that, similar to Mn2+, adhesion to fibronectin induced by these cations is
mediated by VLA-5.
To test if adhesion of BMMC to fibronectin induced by Zn2+, Ni2+ or Co2+ leads
to mast cell degranulation, nonsensitized BMMC were prepared for adhesion,
stimulated with optimal concentrations of Mn2+, Zn2+, Ni2+ or Co2+, incubated
with BSA- or fibronectin-coated polystyrene beads and β-hexosaminidase
release was determined. Figure 4 shows that, in addition to Mn2+, adhesion of
BMMC to fibronectin induced by Ni2+, Co2+ or Zn2+ triggers significant mast cell
degranulation compared to cells incubated with BSA-coated beads. From these
data we conclude that in addition to Mn2+, Ni2+, Co2+ and Zn2+ induce VLA-5
mediated adhesion of BMMC to fibronectin and subsequently induce
degranulation of these cells.
Effect of Mn2+-stimulation on mast cell function in vivo
Our data show induction of adhesion by cations and subsequent triggering of
degranulation of BMMC in an in vitro setup, where cells are incubated in an
artificial microenvironment. To assess the relevance of our findings for mast cell
physiology we extrapolated our model to an in vivo setup. BMMC of BALB/c
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Figure 3. Adhesion of BMMC to fibronectin
induced by divalent cations. BMMC were
prepared for adhesion, stimulated with 0.2 mM
Mn2+, 3 mM Zn2+, 3 mM Ni2+ or 1 mM Co2+ or
no cation (control) and incubated on a
fibronectin (FN)-coated 96 well plate, with
(FN+RGD) or without (FN) soluble RGD, 30
minutes on ice to synchronize adhesion, and
30 minutes at 37°C. Nonadhered cells were
removed by washing and adhesion was
quantified. Means ± SEM, n=4 of a
representative experiment are shown. * p<0.05
by Student’s t-test, compared to control.; #
p<0.05 by Student’s t-test, compared to cation-
stimulated cells incubated in the absence of
soluble RGD.
Figure 4. Degranulation of BMMC triggered
by adhesion to fibronectin induced by
divalent cations. BMMC were prepared for
adhesion, stimulated with 0.2 mM Mn2+, 3 mM
Zn2+, 3 mM Ni2+ or 1 mM Co2+and incubated for
30 minutes with fibronectin (FN)- or BSA-
coated polystyrene beads. Extracellular Ca2+
was supplemented and after 30 minutes β-
hexosaminidase release was measured.
Means ± SEM, n=4 of a representative
experiment are shown. * p<0.05 by Student’s t-
test, compared to cells incubated with BSA-
coated beads.
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origin were used in a modified protocol for passive cutaneous anaphylaxis, in
which in vitro treated cells are locally injected in the skin of BALB/c mice
providing a physiological microenvironment for these cells. Because Mn2+ has
the highest potency to induce adhesion of BMMC to fibronectin and subsequent
degranulation in vitro according to our data, this cation was used for our in vivo
investigations.
Four groups of BMMC were treated in vitro (see also legend figure 5): two
groups were sensitized with anti-DNP IgE, all four groups were treated with
EDTA to remove extracellular Ca2+ and finally one nonsensitized and one
sensitized group were stimulated for 30 minutes with Mn2+. Mice were injected
intradermally at different sites with 5 x 104 cells of each group and
simultaneously injected intravenously with Evans Blue dye (EB).
Subsequently, after 30 minutes mice were challenged by intravenous injection
with 1 mg DNP-HSA to trigger sensitized BMMC and analyzed for EB
extravasation (figure 5B) after another subsequent 30 minutes. As is shown in
figure 5A, at the site of sensitized BMMC significant plasma leakage occurred
(Mn2+/IgE: -/+) compared to untreated cells (Mn2+/IgE: -/-), which indicates that
this method evokes an identical response as the classical passive cutaneous
anaphylaxis protocol. Significant plasma leakage was also observed at the site
of Mn2+-stimulated nonsensitized BMMC (Mn2+/IgE: +/-), although somewhat
lower than the leakage induced by allergen. This response was already visible
macroscopically before the mice were challenged with antigen (data not
shown), and indicates IgE-independent activation of these cells. In all our in
vivo experiments we observed a trend, where stimulation with Mn2+ enhanced
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Figure 5. In vivo mast cell activation induced by Mn2+-stimulation and antigenic
challenge. (A) Naive BALB/c mice were injected intradermally with in vitro-treated BMMC (see
legend, 0.2 mM Mn2+, anti-DNP IgE), and simultaneously injected intravenously with Evans blue
dye (EB). After 30 minutes, mice were antigenically challenged intravenously with 1 mg DNP-
HSA and after additional 30 minutes mice were sacrificed and EB extravasation at the sites of
injected cells was quantified. Blood samples were analyzed for EB content and used for the
calculation of µl extravasated plasma per skin patch. Mean ± SEM, n=6 of a representative
experiment are shown. * p<0.05 by Student’s t-test. (B) Photograph of a representative example
of a stripped dorsal mouse skin, arrows indicate EB extravasation. Injected samples: 1. no
injection; 2. TBS; 3. IgE/Mn2+ -/-; 4. IgE/Mn2+ -/+; 5. IgE/Mn2+ +/-; 6. IgE/Mn2+ +/+.
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allergen-induced mast cell degranulation (Mn2+/IgE: +/+) compared to cells
stimulated with allergen alone (Mn2+/IgE:-/+), however this effect was never
significant.
From these data we conclude that, parallel to our in vitro results, Mn2+-induced
adhesion evokes mast cell degranulation and tends to enhance allergen-
induced degranulation.
Effect of soluble RGD on the function of Mn2+-stimulated cells in vivo
To show that the observed in vivo effects are indeed the result of adhesion to
fibronectin through VLA-5 and exclude a direct effect of Mn2+ on skin reactivity,
we tested the effect of soluble RGD in our in vivo setup. Five groups of cells
received in vitro treatment (see also legend of figure 6): two groups were
sensitized with anti-DNP IgE, all five groups were treated with EDTA to remove
extracellular Ca2+ and finally a sensitized and an nonsensitized group were
stimulated for 30 minutes with Mn2+ alone or with Mn2+ and soluble RGD.
Subsequently, the function of these cells was tested in vivo as described before.
As is shown in figure 6, in vivo mast cell activation by Mn2+-stimulation
(Mn2+/IgE/RGD: +/-/-) is almost abolished by soluble RGD (Mn2+/IgE/RGD: +/-
/+). Soluble RGD also largely attenuated leakage induced by BMMC that were
stimulated with Mn2+ and challenged with allergen, shown by (Mn2+/IgE/RGD:
+/+/+) compared to (Mn2+/IgE/RGD: +/+/-). This suggests that inhibition of VLA-
5 function also affects allergen-induced degranulation. These data show that
Mn2+ stimulation of BMMC induces degranulation of mast cells in vivo by a VLA-
5-dependent mechanism, and suggest that the inhibition of VLA-5 function also
affects FcεRI-induced degranulation.
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Mn2+-stimulation and antigenic
challenge. Naive BALB/c mice were
injected intradermally with in vitro-treated
BMMC (see legend), and simultaneously
injected intravenously with EB. After 30
minutes, mice were antigenically
challenged intravenously and after
additional 30 minutes mice were sacrificed
and EB extravasation at the sites of
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of a representative experiment are shown. *
p<0.05 by Student’s t-test.
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Discussion
Understanding of VLA-5-mediated modulation of mast cell function is potentially
useful for the development of future therapy against mast cell-mediated
diseases and therefore topic of our investigations. In this report we show that
adhesion of BMMC to fibronectin enhanced FcεRI-induced degranulation in
vitro, which is according to  previous data obtained with RBL-2H3 cells62,64,131,155.
Surprisingly, we observed that in absence of an antigenic stimulus, adhesion of
BMMC to fibronectin triggered the degranulation of these cells. Our data show
that adhesion-induced degranulation as well as adhesion-enhanced FcεRI-
mediated degranulation in vitro is mediated by VLA-5, the integrin that was
previously identified as key receptor for mast cell adhesion to fibronectin45,87.
The use of BMMC derived from Balb/c origin enables us to study the function of
these cells after in vitro treatment in their physiological microenvironment,
thereby excluding, for example, possible intrinsic effects of fibronectin density170,
coated to beads in our in vitro setup. The data obtained from our in vivo
experiments confirm the conclusions drawn from our in vitro experiments stating
that cation-induced adhesion of BMMC through VLA-5 triggers degranulation of
these cells. The effect of Mn2+-induced adhesion on FcεRI-induced
degranulation did not reach statistical significance when compared to cells
stimulated with allergen alone in our in vivo experiments, although a trend for
enhancement was observed. This may be explained by a limitation of plasma
leakage per area of skin and therefore nonlinearity with mast cell degranulation
at sites of strong activation.
Activation of integrins leading to adhesion and migration of various cells can be
induced by a range of mediators such as interleukins79,141, chemokines99,171 and
growth factors such as SCF13,36,167. Our findings show that VLA-5-mediated
adhesion can augment FcεRI-induced degranulation. This could be the result of
a lowering of the activation threshold of FcεRI. This implies that by local
induction of adhesion, for example at sites of tissue inflammation, mast cells
can be primed for antigenic stimulation by their microenvironment. Our data
suggest that in vivo blocking of VLA-5 attenuates allergen-induced
degranulation, which implies that by prevention of mast cell adhesion these
cells become less sensitive for antigenic stimulation. This conclusion is
supported by previous data showing that passive cutaneous anaphylaxis is
blocked by injection of anti-VLA-5 antibody177. In in vitro experiments this
phenomenon will not be observed, because the availability of allergen for a
sensitized mast cell is virtually unlimited, therefore the activation threshold can
always be exceeded. However, in vivo allergen concentrations reaching the
local sensitized mast cells is limited and therefore the mast cell will no longer be
optimally activated because the priming effect of VLA-5 is lost. On resting mast
cells located in uninflamed tissues, VLA-5 will be present in a low-affinity state
and therefore these cells, although sensitized, will not be primed for an
antigenic challenge. Vice versa it has been demonstrated that FcεRI-stimulation
induces VLA-5 mediated adhesion to fibronectin87. In our experiments we find
that the optimal allergen concentration needed for mast cell adhesion to
fibronectin is, at least tenfold, lower than for degranulation (unpublished
observations). VLA-5 on nonprimed mast cells could therefore be initially
converted to high-affinity by low concentrations of allergen, subsequently
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inducing adhesion to fibronectin and priming of the cells for antigenic challenge,
via this ‘positive-feedback’ mechanism degranulation and adhesion can be
mutually enhanced.
In case of optimal stimulation of VLA-5, which in our experiments is induced by
Mn2+-stimulation the FcεRI activation threshold appears to be exceeded
spontaneously and degranulation is induced without the presence of an
antigenic stimulus. As discussed earlier, integrin-mediated adhesion can be
induced by various inflammatory mediators and therefore optimal stimulation of
VLA-5 in vivo may easily occur in chronically inflamed tissues or at sites of
severe anaphylaxis where inflammatory mediators are abundantly
present2,90,101,137.
In our experiments, we find that various divalent cations are able to induce mast
cell adhesion and subsequent degranulation in absence allergen. In literature
there are numerous examples of contact hypersensitivity responses towards
manganese, zinc, nickel and cobalt9,57,92,119,148, however the underlying
mechanisms are poorly understood. Our data suggest a plausible explanation
for hypersensitivity responses to various metals. These responses could very
well be the result of cation-induced high-affinity of VLA-5 on local mast cells;
thereby inducing adhesion to fibronectin and subsequent triggering of allergic
mediator release from mast cells.
In summary, we have shown that VLA-5-mediated adhesion of mast cells to
fibronectin primes these cells for antigenic stimulation and that prevention of
adhesion reduces allergen-induced degranulation, which indicates possible
future targets for therapy against allergy. Furthermore, our data show that
cations can induce VLA-5-mediated adhesion and subsequent activation of
mast cells, providing a possible mechanism for allergic reactions to metals in
vivo.
VLA-5-mediated adhesion of bone marrow-derived
mast cells to fibronectin triggers FcεRI signaling
and subsequent degranulation
René Houtman, Jeanette H. W. Leusen†, Janine Schuurman,
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Abstract
Adhesion to fibronectin through very late antigen-5 (VLA-5) enhances allergen-
induced mast cell degranulation in RBL-2H3 cells. In the present study, we use
mast cells derived from murine bone marrow (BMMC) to study this effect in
more detail. Adhesion of BMMC was induced through Mn2+-stimulation, which
converts VLA-5 into a high-affinity conformation for fibronectin. Our data show
that adhesion not only enhances allergen-induced degranulation but also
directly triggers degranulation in absence of allergen. Absence of FcεRI-γ did
not affect adhesion but abrogated adhesion-induced degranulation.
Furthermore, degranulation and confocal microscopy indicated membrane
colocalization of VLA-5 and FcεRI on resting BMMC. Adhesion of BMMC to
fibronectin-coated beads induced accumulation of FcεRI-γ and Syk with the cell
fraction associated with these beads, suggesting association with focal
adhesion complexes. Moreover adhesion and allergen stimulation induced an
identical protein tyrosine phosphorylation pattern.This indicates that both stimuli
trigger the same signal transduction cascade. Disruption of rafts by cholesterol
depletion, inhibited adhesion as well as adhesion-induced degranulation, while
ionomycin-induced degranulation was not affected. This indicates a role for
these membrane microdomains in VLA-5 function. In summary, our data
suggest that adhesion of BMMC to fibronectin induces clustering of VLA-5 and
physically associated FcεRI at the cell-substrate interface. This aggregation of
FcεRI and possible association with rafts could induces the initiation of the
FcεRI signaling cascade and subsequent degranulation. Regulation of the
degree of adhesion and subsequent (pre-)clustering of FcεRI could thereby
serve as a modulating mechanism for allergen-induced mast cell activation.
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Introduction
Mast cells are localized in all vascularized tissues and play an important role in
hypersensitivity type I responses147. Antigenic stimulation of these cells via the
high affinity receptor for IgE (FcεRI)i triggers a signal transduction cascade
leading to the release of various inflammatory mediators, which cause clinical
phenomena associated with allergy12,14,59.
Adhesion of mast cells to extracellular matrix component fibronectin enhances
allergen-induced degranulation62,64,131,155, and it has been established that
interaction of mast cells with fibronectin is mediated by the α5β1-integrin very
late antigen-5 (VLA-5)150,177. Interestingly, we recently found that adhesion of
murine bone marrow-derived mast cells (BMMC) to fibronectin, induced by
conversion of VLA-5 to high affinity with Mn2+ 7,116,118, triggers degranulation in
absence of an antigenic stimulus. The mechanism by which adhesion itself
induces degranulation and modulates allergen-induced degranulation is not yet
understood and is topic of this report.
Aggregation of FcεRI by binding of multivalent allergen to FcεRI-bound IgE
causes this receptor to associate rapidly with rafts, which are specialized
cholesterol-enriched plasma membrane regions47-49,152. Subsequently, active
protein tyrosine kinase (PTK) Lyn, enriched within rafts, phosphorylates the
tyrosine residues of the immunoreceptor tyrosine-based activation motifs
(ITAM) located in the cytoplasmic tails of the FcεRI β- and γ-subunits161.
Phosphorylation of the FcεRI-γ ITAMs leads to the recruitment, tyrosine
phosphorylation and activation of cytosolic Syk, which has been shown to be
critical for the induction of degranulation32,132,161. Disruption of rafts by cholesterol
depletion impairs the interaction of aggregated FcεRI and Lyn and attenuates
initiation of the FcεRI signal transduction cascade in RBL-2H3 mast cells143.
Clustering of integrins by binding to extracellular matrix components, induces
the formation of focal adhesion complexes (at the locus of cell-matrix
attachment22,33,100. Integrin-mediated modulation of signaling of the growth factor
receptor family has been well documented27,113,135 and several reports suggest
that this modulation takes place within the focal adhesion complexes where
these receptors are physically associated with integrins126,153. Considering the
similarities between FcεRI and growth factor receptors63,136,161, we investigated
whether modulation of degranulation by VLA-5 may also take place in the focal
adhesion complexes by physical interaction between this integrin and FcεRI.
In this report we have investigated if FcεRI plays a role in adhesion-induced
degranulation of BMMC. Furthermore we studied the distribution of FcεRI and
VLA-5 on these cells, analyzed the contents of the insoluble fraction of adhered
and nonadhered cells for the presence of FcεRI signaling components, and
propose a possible mechanism for VLA-mediated modulation of FcεRI
signaling.
                                                          
i For abbreviations see page 101
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Materials & Methods
Animals
6-8 Weeks old male BALB/c mice were obtained from Central Animal Laboratory
(GDL), Utrecht University, Utrecht, The Netherlands. FcεRI-γ knock out mice164 were
kindly provided by Prof. T. Saito, Div. Mol. Genet., Chiba Univ. Grad. Sch. Med., Chiba,
Japan. The experiments were approved by the Animal Care Committee of the Utrecht
University.
Cells
BMMC were obtained as described previously84. Briefly, bone marrow from mouse
femurs, was flushed and cells were cultured at a density of 2 x 105/ml in complete
RPMI (RPMI 1640 medium, 4 mM L-glutamine, 5 x 10-5 M β-mercaptoethanol, 1 mM
sodium pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin, and 0.1 mM
nonessential amino acids) supplemented with 20 %(vol/vol) supernatant from BALB/c
splenocytes stimulated for 7 days with pokeweed mitogen (Sigma Aldrich NV/SA, Axel,
The Netherlands). Medium was refreshed once per week. In all experiments 4-6 weeks
old BMMC were used.
Immobilization of fibronectin
NUNC maxisorp 96-well plates were incubated for 3 hours at 37°C with 2.5 mg/ml
human fibronectin (C.L.B., Amsterdam, The Netherlands) in Tris-buffered saline (TBS,
2.9 g/L Tris-Cl, 4 g/L NaCl, 0.2 g/L KCl, 0.4 g/L glucose, 0.1 % BSA), 200 µl/well,
washed 3 times with 200 µl/well PBS, and used for cell adhesion experiments.
Polystyrene beads (average diameter 11.9 µm, Sigma Aldrich NV/SA, Axel, The
Netherlands) were incubated for 1 hour at room temperature with 2.5 mg/ml human
fibronectin (CLB, Amsterdam, The Netherlands) or 1% BSA (Sigma Aldrich NV/SA,
Axel, The Netherlands) in TBS as control for non-adhered cells, under constant
rotation, followed by three times washing with an excess volume of TBS and used for
mast cell degranulation experiments.
Cholesterol depletion of cells
BMMC were washed twice with complete RPMI without FCS, and incubated at a
density of 2.5 x 106 cells/ml for 30 minutes at 37°C with 10 mM methyl-β-cyclodextrin
(Sigma Aldrich NV/SA, Axel, The Netherlands) in complete RPMI. Subsequently, cells
were prepared for adhesion.
Preparation of cells for degranulation and adhesion
Sensitization of BMMC was performed by incubation of the cells with culture
supernatant of hybridoma 26.82 containing dinitrophenyl(DNP)-specific IgE98, for 1 hour
at 37°C. For adhesion cells were washed once with PBS, once with 1 mM EDTA in
PBS at 37°C, once with TBS and resuspended in TBS for experimental use.
Adhesion of BMMC to fibronectin
For adhesion on a fibronectin-coated 96-well plate, BMMC were prepared as
described, 5 x 104 cells per well were incubated with 0.2 mM Mn2+ (the concentration
that induces maximal adhesion, empirically determined) for 30 minutes on ice to
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synchronize adhesion of the cells. Subsequently, the 96-well plate was transferred to
37°C and after 30 minutes non-adhered cells were removed by washing of the plate
(three times, 200 µl/well).
For adhesion to beads, BMMC were prepared as described, incubated with 0.2 mM
Mn2+, mixed with a pellet of fibronectin- or BSA coated beads (beads:cells ratio = 1:1)
and centrifuged briefly to pellet the cells and beads. The pellet was then incubated at
37°C for 5 minutes, gently resuspended and incubated for an additional 25 minutes at
37°C.
Quantification of adhesion
Adhesion to fibronectin-coated 96-well plates was quantified using Cyquant
proliferation assay kit (Molecular Probes Europe BV, Leiden, The Netherlands)
according to the manufacturer’s protocol. In short, samples were frozen overnight at -
20°C, thawed and incubated for 60 minutes under continuous agitation at room
temperature with a DNA-specific fluorescent dye and lysing reagent. Fluorescence was
measured at λex.: 485nm/λem.: 530nm using a Millipore Cytofluor 2350 microplate
reader and adhesion was calculated as the residual fluorescence as percentage of
input fluorescence.
Measurement of degranulation
Per volume of the BMMC/bead mixture, 14 volumes of Tyrode’s buffer (0.1 M Tyrode
salts: Life Technologies BV, Breda, The Netherlands; 100 mM HEPES/ 0.1 % NaHCO3,
pH 7.2; supplemented with 0.1 % BSA) were added to supplement extracellular Ca2+.
Per sample, 5 x 104 cells of the cell/bead mixture were incubated with 10 ng/ml human
serum albumin (HSA)-conjugated DNP (DNP-HSA, Sigma Aldrich NV/SA, Axel, The
Netherlands) or with Tyrode’s buffer alone, and after 30 minutes at 37°C 50 µl
supernatant of each sample was collected. Samples of 5 x 104 unstimulated cells of
each treatment-group were lyzed using 0.1 % NP-40 (Omnilabo International, Breda,
The Netherlands) in order to quantify the total granular β-hexosaminidase activity
present in these cells. Supernatants and lysates were analyzed for β-hexosaminidase
activity as described previously84. In short, samples were incubated for 60 minutes at
37°C with 4-methylumbelliferyl-N-acetyl-β-D-glucosaminide (4-MUG, Sigma Aldrich
NV/SA, Axel, The Netherlands) and the reaction was stopped with glycine buffer (0.2
M, pH 10.7). Hydrolysis of 4-MUG was determined by fluorimetric measurement (λex:
360nm/λem: 452nm) using a Millipore Cytofluor 2350 microplate reader. The percentage
of degranulation was calculated as follows:100% x fluorescencesupernatant/fluorescencecell
lysate. β-Hexosaminidase release was corrected for β-hexosaminidase activity found in
the supernatant of nonchallenged BMMC incubated with BSA-coated beads. All graphs
show mean values ± SEM of a representative of three experiment in which each
condition was performed in quadruplicate.
Membrane expression of VLA-5
Cells were incubated for 30 minutes at 4°C with Fluorescein Isothiocyanate (FITC)-
conjugated103 anti-VLA-5 antibody, BMA5 (kindly provided by Dr B.M.C. Chan,
Transplantation and Immunobiology group, Univ. Western Ontario, Canada)45, in FACS
buffer (0.1 % BSA, 0.1 % sodium azide in PBS), washed and resuspended in FACS
buffer. Fluorescence was analyzed by flow cytometry using FACScan, and PC-lysis
software.
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Membrane distribution of FcεRI and VLA-5 on BMMC
BMMC were incubated in complete RPMI in suspension for 60 minutes at 37°C with
FITC-conjugated anti-VLA-5 antibody, BMA5, and Indocabocyanine Cy3 (Cy3)-
conjugated IgE (purified from 26.82 culture supernatant). Subsequently cells were
washed twice with TBS, incubated for 30 minutes at 37°C on poly-L-lysine coated
object slides, fixed for 20 minutes at room temperature with 4% paraformaldehyde and
washed twice with PBS. Samples were mounted in Mowiol containing 2.5 % DABCO
and examined with a 63x planapo objective on a Leitz DMIRB fluorescence microscope
(Leica, Voorburg, The Netherlands) interfaced with a Leica TCS4D confocal laser
microscope (Leica, Heidelberg, Germany) using the following filters: FITC, λex = 488
nm and λem = 520 nm band pass; and Cy3, λex = 568 nm and λem = 590 nm long pass.
Images were imported and processed in Adobe Photoshop 4.0 (Adobe Systems Inc,
San Jose, CA, USA).
Western blot analysis of bead-associated proteins
Mn2+-stimulated BMMC were incubated for indicated time intervals with fibronectin- or
BSA-coated beads as described above and, when indicated, antigenically challenged
for 1 minute with 300 ng/ml DNP-HSA. Per sample, 5 x 106 cells were briefly
centrifuged to pellet cells and beads, supernatant was discarded and cells were lysed
with icecold lysis buffer (0.15 M NaCl, 50 mM, Tris, 1 mM EDTA, 1 mM sodium
orthovanadate, 10 mM tetrasodium pyrophosphate, 0.5 mM sodiumfluoride, 1 mM
PMSF, 1 % NP-40, pH 7.4, and Complete Mini protease inhibitors (Boehringer
Mannheim BV, The Netherlands)) After 30 minutes incubation on ice, samples were
centrifuged at 4°C 15.000 g.for 30 minutes and supernatants were discarded. Pellets
were resuspended in 20 µl sample buffer (3 % SDS, 7.5 %(vol/vol) glycerol, 0.05 M Tris
and 0.5 mg/ml bromophenol blue and 10 mM DTT) boiled for 5 minutes, separated on
12.5 % bis-/acrylamide gel (Bio-Rad Laboratories BV, Veenendaal, The Netherlands)
and blotted on PVDF membrane (Costar Europe Ltd., Badhoevedorp, The
Netherlands). Tyrosine phosphorylation was detected with horseradish peroxidase
(HRP)-conjugated PY99 (Santa Cruz Biotechnology, Inc). FcεRI-γ was detected with a
rabbit polyclonal antibody (a generous gift from Dr. M. -H. Jouvin, Beth. Israel
Deaconess Med. Ctr., Boston, USA )123 and Syk was detected with a rabbit polyclonal
antibody (kindly donated by Dr. U Blank, Inst. Pasteur, Paris, France)110 and HRP-
conjugated horse anti-rabbit polyclonal (C.L.B., Amsterdam, The Netherlands) and
visualized with Supersignal Substrate (Pierce, Rockford IL, U.S.A.) and exposure to
KODAK X-OMAT-AR film. Films were scanned and analyzed on a GS710 Calibrated
Imaging Densitometer and Quantity One v. 4.0.3 software (both Bio-Rad Laboratories
BV, Veenendaal, The Netherlands).
Results
Effect of Mn2+-induced adhesion of BMMC to fibronectin on degranulation
To show that Mn2+-induced adhesion of BMMC to fibronectin triggers
degranulation and enhances FcεRI-induced degranulation, BMMC were
sensitized with anti–DNP IgE, prepared for adhesion by removal of extracellular
Ca2+ with EDTA, and stimulated with 0.2 mM Mn2+ to convert VLA-5 to its high-
affinity state. Additionally, cells were incubated for 30 minutes at 37°C with
fibronectin-coated beads or with BSA-coated beads as control for nonadhered
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cells. Extracellular Ca2+, critical for degranulation11, was supplemented, cells
were antigenically challenged with DNP-HSA and β-hexosaminidase release as
measure for mast cell degranulation was quantified. As is shown in figure 1,
incubation of BMMC with fibronectin- but not BSA-coated beads induces
release of β-hexosaminidase in the absence of allergen. Furthermore, adhesion
to fibronectin enhances allergen-induced degranulation compared to cells
incubate with BSA-coated beads. These results suggest that adhesion to
fibronectin only generates sufficient signals to induce granule exocytosis from
mast cells.
Adhesion of BMMC derived from FcεRI-γ knockout mice
To be able to test for a possible role for FcεRI, in adhesion-induced
degranulation, we generated BMMC from mice lacking the γ-subunit of FcεRI
due to targeted gene disruption, and characterized them. As is shown in figure
2A, the average VLA-5 expression on wild type and FcεRI-γ knock out BMMC,
determined by FACS analysis, was found to be comparable. Additionally, we
tested if an equivalent level of VLA-5 expression correlates with comparable
adhesion of wild type and knock out BMMC to fibronectin. Cells were prepared
for adhesion, stimulated with Mn2+ and incubated on a fibronectin-coated 96-
well plate, a setup which allows us to remove nonadhered cells by washing and
quantify adhesion. As is shown in figure 2B, Mn2+-induced adhesion of BMMC
to fibronectin is comparable between cells with and without FcεRI-γ. From these
data we conclude that the γ-subunit of FcεRI is not required for VLA-5 mediated
adhesion of BMMC to fibronectin.
Adhesion-induced degranulation of BMMC lacking FcεRI-γ
To investigate if the γ-subunit of FcεRI plays a role in degranulation triggered by
adhesion of BMMC to fibronectin, wild type and knock out cells were prepared
for adhesion, stimulated with Mn2+, incubated with fibronectin- or BSA-coated
beads and analyzed for β-hexosaminidase release. As is shown in figure 3,
incubation of wild type BMMC with fibronectin- but not BSA-coated beads
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e Figure 1. Effect of adhesion to fibronectinon β-hexosaminidase release of BMMC.
Anti-DNP IgE-sensitized BMMC were
prepared for adhesion, stimulated with 0.2
mM Mn2+ and incubated for 30 minutes with
fibronectin (FN)- or BSA-coated polystyrene
beads. Subsequently, extracellular Ca2+ was
supplemented (final concentration: 1.8 mM)
and cells were antigenically challenged (DNP)
or not (control) with 10 ng/ml DNP-HSA.
After 30 minutes β-hexosaminidase release
was quantified.
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triggers release of β-hexosaminidase, however in BMMC lacking the γ-subunit
of FcεRI this phenomenon was not observed. Ionomycin-induced degranulation
of wild type and knock out cells, bypassing the initial steps of the FcεRI-
signaling cascade, was found to be comparable indicating that knock out BMMC
are fully capable of degranulation (data not shown). From these data we
conclude that FcεRI-γ plays a critical role in degranulation of BMMC induced by
adhesion of these cells to fibronectin.
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Figure 3. A role for FcεRI-γ in adhesion-
induced β-hexosaminidase release of
BMMC. BMMC derived from wildtype (WT)
and FcεRI-γ knock out (γ-KO) mice, were
prepared for adhesion, stimulated with 0.2
mM Mn2+ and incubated for 30 minutes with
fibronectin (FN)- or BSA-coated polystyrene
beads. Subsequently, extracellular Ca2+ was
supplemented (final concentration: 1.8 mM)
and after 30 minutes β-hexosaminidase
release was determined.
Figure 2. Characterization of BMMC derived from FcεRI-γ knock out mice. (A) Histogram of
VLA-5 expression of BMMC derived from wild type (WT) and FcεRI-γ knock out (γ-KO) mice, as
determined by staining with FITC-conjugated anti-VLA-5 antibody BMA-5 and FACS analysis.
Nonstained cells serve as negative control (n.c.). (B) BMMC derived from wild type (WT) and
FcεRI-γ knock out (γ-KO) mice were prepared for adhesion, stimulated with 0.2 mM Mn2+, and
incubated on a fibronectin-coated 96-well plate, 30 minutes on ice to synchronize adhesion, and
30 minutes at 37°C. Nonadhered cells were removed by washing and adhesion was quantified.
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Membrane distribution of FcεRI and VLA-5 on BMMC
One mechanism by which FcεRI-γ could play a role in adhesion-induced
degranulation is through physical interaction between these proteins. We
therefore investigated whether VLA-5 and FcεRI are colocalized on resting
BMMC. These receptors were visualized by incubation of BMMC with TRITC-
labeled IgE, to detect FcεRI, and FITC-labeled anti-VLA-5 antibody BMA5. Cells
were fixed on poly-L-lysine-coated object slides and examined by confocal
microscopy. As is shown in figure 4, the distribution of VLA-5, shown in green
(left panel), largely corresponds with that of FcεRI, shown in red (middle panel),
on BMMC. This is confirmed by overlaying the two pictures as shown in the
right panel of figure 4, of which the yellow staining is indicative for codistribution
on the plasma membrane. From these data we conclude that, within the spatial
resolution of the confocal microscope (0.3 µm), VLA-5 and FcεRI are, at least
partially, colocalized on the surface of BMMC.
Effect of adhesion to fibronectin on the distribution of FcεRI signal
transduction components
The observation that FcεRI colocalizes with VLA-5 raised the question if
adhesion of these cells to fibronectin-coated beads induces a redistribution of
FcεRI signal transduction components to the sites where VLA-5 is clustered.
IgE-sensitized BMMC were prepared for adhesion, stimulated with Mn2+ and
incubated with BSA- or fibronectin-coated beads. Next, cells were incubated in
the absence or presence of DNP-HSA and subsequently lyzed, leaving a mix of
detergent-soluble and -insoluble components. The latter fraction that contains
cytoskeletal proteins and beads with -associated cell components, was isolated
by centrifugation and boiled with SDS to disrupt this association. Subsequently,
these samples were analyzed by Western blotting. As shown in figure 5A,
incubation of cells with fibronectin-coated beads increases the amount of FcεRI-
γ in the insoluble fraction of cells compared to cells incubated with BSA-coated
beads. This suggests that FcεRI-γ associates with beads upon adhesion,
probably within the focal adhesion complexes where interaction with fibronectin
takes place. Antigenic stimulation of the cells increased the amount of FcεRI-γ
Figure 4. Distribution of FcεRI and VLA-5 on BMMC. BMMC were stained in suspension with
TRITC-conjugated IgE (left panel) and FITC-conjugated anti-VLA-5 antibody BMA5 (middle
panel), fixed on object slides and analyzed by confocal microscopy. The obtained pictures were
merged and resulting yellow signal indicated colocalization of the FITC- and TRITC-signal (right
panel).
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takes place. Antigenic stimulation of the cells increased the amount of FcεRI-γ
in the insoluble fraction only in cells incubated with fibronectin-coated beads.
This suggests that antigenic stimulation induces aggregation of additional,
detergent-soluble or ‘free’, FcεRI with FcεRI that is already immobilized in focal
adhesion complexes due to adhesion.
To investigate if adhesion of BMMC induces association of Syk with beads in
adhered cells, we analyzed the insoluble fraction of adhered cells for Syk
content by western blotting. As shown in figure 5B, adhesion to fibronectin also
triggers a time-dependent redistribution of Syk to the insoluble fraction. This
probably reflects the recruitment of Syk from the cytoplasm to phosphorylated
focal adhesion complex-associated FcεRI-γ.
Additional analysis of the insoluble fractions of adhered and non-adhered cells
shows that adhesion triggers the accumulation of various tyrosine
phosphorylated proteins within the fraction of adhered cells (figure 5C).
Interestingly, the pattern of phosphorylation induced by adhesion is similar to
that found in antigenically challenged non-adhered cells. Furthermore, the
highest degree of tyrosine phosphorylation is achieved in cells that are
stimulated, both by adhesion and allergen. These data suggest that clustering
of FcεRI in focal adhesion complexes, due to adhesion of BMMC to fibronectin,
and clustering of this receptor by multivalent allergen can lead to the initiation of
the same signal transduction cascade.
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Figure 5. Association of cell components
with the insoluble fraction of BMMC
adhered to fibronectin. Anti-DNP IgE-
sensitized BMMC were prepared for adhesion
and stimulated with 0.2 mM Mn2+. (A and C)
Cells were incubated for 30 minutes with
fibronectin (FN)- or BSA-coated polystyrene
beads. Cells were antigenically challenged or
not for 1 minute with 300 ng/ml DNP-HSA. (B)
Cells were incubated for 5 minutes with BSA-
coated polystyrene beads or 1, 2, 5 or 15
minutes with FN-coated polystyrene beads.
Subsequently cells were lyzed with 1 % NP40
and the insoluble fraction was analyzed for (A)
FcεRI-γ or (B) Syk or (C) tyrosine
phosphorylation by Western blotting.
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Effect of cholesterol depletion on adhesion and adhesion-induced
degranulation
To investigate a possible role for rafts in adhesion-induced degranulation,
BMMC were treated with methyl-β-cyclodextrin (β-CD) to deplete membrane
cholesterol to disrupt raft architecture and function78. This treatment did not
affect membrane integrity as determined by measurement of propidium iodide
cell entrance (data not shown). Treated and nontreated BMMC were prepared
for adhesion, stimulated with Mn2+ and incubated on a fibronectin-coated 96-
well plate. Nonadhered cells were removed by washing and adhesion was
quantified. As is shown in figure 6A, β-CD treatment of BMMC severely disturbs
adhesion to fibronectin.
Attenuated adhesion should also result in abrogation of adhesion-induced
degranulation. To confirm this, β-CD treated and nontreated sensitized BMMC
were incubated with BSA- or fibronectin coated beads, and β-hexosaminidase
release was determined. As is shown in figure 6B, β-hexosaminidase release
induced by incubation with fibronectin-coated beads is completely inhibited after
β-CD treatment. From these data we conclude that rafts are important for VLA-5
function and adhesion of BMMC to fibronectin and thereby play a role in
adhesion-induced degranulation of these cells.
Discussion
In this report we show that adhesion of BMMC to fibronectin not only enhances
allergen-induced degranulation, but also directly induces degranulation.
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Figure 6. Effect of cholesterol-depletion on adhesion and adhesion-induced
degranulation. BMMC were treated or not with methyl-β-cyclodextrin (β-CD) or not (control),
prepared for adhesion and stimulated with 0.2 mM Mn2+. (A) Cells were incubated on a
fibronectin-coated 96-well plate, 30 minutes on ice to synchronize adhesion, and 30 minutes at
37°C. Nonadhered cells were removed by washing and adhesion was quantified. (B) Cells were
incubated for 30 minutes with fibronectin (FN)- or BSA-coated polystyrene beads, extracellular
Ca2+ was supplemented (final concentration: 1.8 mM) and after 30 minutes β-hexosaminidase
release was determined.
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Adhesion of BMMC to fibronectin has been shown to be mediated by VLA-545,87
and we previously showed that adhesion-induced degranulation can be blocked
by soluble arginin-glycine-aspartic acid peptide.
Our data show that presence of FcεRI-γ, although not needed for adhesion
itself, is required for the induction of degranulation by adhesion and this strongly
suggests physical interaction between VLA-5 and FcεRI. Within the spatial
resolution of the confocal microscope, VLA-5 and FcεRI appear to be
colocalized on resting BMMC. In our experiments the α-subunit of FcεRI was
detected by fluorescently stained IgE. Because FcεRI-α can not exist
independently of β- or γ-subunits on the cell membrane, we consider the
observed fluorescence as indicative for the presence of the complete FcεRI
complex. Previous transfectant studies have shown physical association
between αmβ2 integrin CR3 and Fcγ receptors127,174, which suggests that physical
association between VLA-5 and FcεRI may be possible. Moreover, adhesion of
BMMC to fibronectin-coated beads and subsequent clustering of VLA-5 results
in association of FcεRI-γ with these beads which suggests that FcεRI
comigrates with VLA-5, possibly due to physical association, into focal adhesion
complexes.
Our study shows that cholesterol depletion attenuates adhesion of BMMC to
fibronectin and this indicates that membrane rafts play a role in VLA-5 function,
as was previously shown to be the case for αLβ2 integrin LFA-1 on T-
lymphocytes89. Rafts are enriched with Src-kinases20, which play an important
role in focal adhesion complex-formation22,33. Association of clustered VLA-5
with rafts would also lead to redistribution of co-associated FcεRI to these
microdomains, where the FcεRI signaling is initiated by phosphorylation of the
receptor subunits by Lyn. Interestingly, attachment of bronchial epithelial cells to
fibronectin through β1 integrins, prevents these cells from dying when deprived
from growth factors5, and integrin-mediated adhesion of fibroblasts to fibronectin
induces platelet-derived growth factor receptor phosphorylation in absence of
growth factors153. In these two studies the growth factor receptors were shown
to be localized in the focal adhesion complexes and this suggests that
fibronectin serves as “pseudo-growth factor” because integrin aggregation
induces clustering and activation of physically associated growth factor
receptors. Analogous to this mechanism, fibronectin could function as “pseudo-
allergen”, clustering FcεRI that is physically associated with aggregated VLA-5.
Syk activation by integrins has been demonstrated in various reports53,60,97,109,176.
and the presence of the γ-subunit normally used by Fc receptors, was found to
be obligatory for integrin-induced Syk activation128. Accordingly, we show that
adhesion-induced degranulation is FcεRI-γ-dependent and that adhesion
induces the recruitment of Syk to the insoluble fraction, probably to the
phosphorylated γ-subunit within the focal adhesion complexes. Activation of
Syk, through binding to FcεRI-γ ITAM, is critical as well as sufficient for
degranulation32,132. In our experiments, adhesion and FcεRI-stimulation induce a
similar pattern of tyrosine phosphorylation associated with the insoluble fraction
of the cells. This suggests that adhesion induces Syk recruitment and initiation
of the signal transduction cascade leading to degranulation, which is also
triggered by clustering of FcεRI by multivalent allergen.
In our experiments we use cells with optimally stimulated VLA-5, as assessed
empirically (data not shown), and our data suggest that adhesion of these cells
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leads to clustering of a sufficient amount of FcεRI to exceed the activation
threshold of this receptor in absence of allergen. Suboptimal VLA-5 stimulation,
could induce clustering of a small amount of FcεRI. In this case the activation
threshold is not exceeded but these cells are primed for FcεRI-stimulation due
to the preclustered state of this receptor. According to ‘kinetic proofreading’,
stabilization of FcεRI aggregates at focal adhesion complexes, thereby
enhancing their lifetime in the aggregate, may also enhance degranulation. The
concept of kinetic proofreading postulates that the biological potency of an
individual receptor is determined by its lifetime within a signaling aggregate71,104
and was shown to apply for FcεRI signaling159.
Activation of integrins can be induced by a range of mediators such as
interleukins79,141, chemokines99,171 and growth factors such as SCF13,36,167. Subtle
variations in conditions of the mast cell microenvironment, for example at sites
of inflammation where integrin-activating mediators are abundantly present,
could thereby regulate mast cell sensitivity for antigenic stimulation.
In summary, our data suggest that VLA-5 clustering through adhesion to
fibronectin induces aggregation of FcεRI in focal adhesion complexes and
thereby triggers the FcεRI signal transduction cascade leading to mast cell
degranulation.
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Although the underlying mechanisms remain elusive, the incidence of allergy
has increased rapidly during the last century and has reached epidemic
proportions69. Various lines of evidence indicate that the function of mast cells,
the major effector cell type in allergy, is modulated by microenvironmental
factors. In all tissues, mast cells are surrounded by the extracellular matrix-
component fibronectin. A key receptor involved in mast cell-fibronectin
interaction is very late antigen-5 (VLA-5)i, and this integrin has been shown to
be a potent enhancer of allergen-induced mast cell degranulation in vitro and in
vivo35,64,91,131,155,177. Understanding of the mechanism by which VLA-5 modulates
mast cell function is of potential interest for the development of future therapy
against allergy and was therefore chosen to be the subject of this thesis. The
main findings of the thesis are summarized in this general discussion.
Choice of experimental setup
Enhancing effects on degranulation induced by VLA-5-mediated adhesion to
fibronectin, were initially reported in RBL-2H3 mast cells35,64,155. These cells have
been shown invaluable for the investigation of signaling through the high-affinity
for IgE (FcεRI), and are still widely used as in vitro model for mast cells. For
detailed study of adhesion-mediated modulation of mast cell degranulation, an
in vitro model system is required in which these cell functions can be controlled
independently. A typical feature of RBL-2H3, however, is adhesion to various
surfaces without the assembly of specialized adhesion structures at the cell-
substrate interface8,124. This major discrepancy with in vivo mast cells makes
RBL-2H3 cells unsuitable for our investigations.
The development of techniques to culture mast cells from murine bone-marrow
(BMMC) has opened a new field of possibilities for in vitro mast cell
research84,133. Through variations in culture conditions, maturation into different
BMMC subtypes can be induced. The phenotypes and responses to various
stimuli, such as allergen, of these cells are comparable to the different mast cell
populations found in vivo. Most importantly BMMC cells do not adhere
spontaneously or nonspecifically to fibronectin. In our opinion, BMMC are the
most accurate in vitro representation of mast cells currently available, and we
therefore use these cells for our investigations.
For adhesion of BMMC to fibronectin, a conformational change of VLA-5 into a
high-affinity state is required. In chapter 4, we present a protocol using Mn2+ as
a stimulus to induce a high-affinity state of VLA-5. A major advantage of Mn2+
compared to other known adhesion–inducing stimuli, is that this cation does not
affect FcεRI signaling directly.
Characterization of Mn2+-induced adhesion indicates two phases. During the
first phase, a conformational change of the integrin enables ligand binding and
during the second stage, increased intracellular kinase and phosphatase activity
leads to a stabilized cell-substrate bond. These features, referred to as inside-
out and outside-in signaling respectively, are characteristic for integrin
physiology58,74 and make this model suitable for our purposes.
                                                          
i For abbreviations see page 101
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VLA-5: enhancer and initiator of degranulation
The effects of VLA-5-mediated adhesion on degranulation of BMMC are
presented in chapter 6. We demonstrate that adhesion enhances allergen-
induced degranulation. This confirms a regulatory role in degranulation for VLA-
5 in BMMC, cells that are a proper reflection of mast cells in vivo. Besides
enhancing the response to allergen, we demonstrated that VLA-5-mediated
adhesion to fibronectin directly triggers degranulation in the absence of an
allergic stimulus, both in vitro and in vivo.
Overall, our data suggest that the degree of adhesion, determined by the
affinity-state of VLA-5, correlates with allergen sensitivity and magnitude of
degranulation of mast cells. Further analysis, as discussed below, suggests that
both initiation and enhancement of degranulation by adhesion may be the result
of the same mechanism through which VLA-5 and FcεRI interact.
A model for VLA-5 mediated modulation of mast cell degranulation
In chapter 7, the characteristics of adhered and nonadhered BMMC were
studied and described in more detail. We found that on the membrane of BMMC
VLA-5 and FcεRI are colocalized and that the FcεRI γ-subunit is required for,
allergen-independent, adhesion-induced degranulation. Analogous to integrin
CR3 and FcγRIIA, as demonstrated by Worth et al.174, VLA-5 and FcεRI may be
physically associated on the mast cell membrane. Additionally, we demonstrate
that in adhered BMMC FcεRI-γ and subsequently Syk are accumulated in the
fibronectin-associated cell fraction. Furthermore, adhesion to fibronectin and
FcεRI-stimulation trigger tyrosine phosphorylation of an identical set of proteins,
which is additive when both stimuli are applied. Similar data have been
demonstrated for β1 integrins in relation to members of the growth factor-
receptor (GF-R) family by Aoshiba et al. and Sundberg et al.. In these studies,
adhesion to fibronectin-induced coclustering of β1 integrins and GF-R in focal
adhesion complexes, induced growth factor-independent phosphorylation of the
GF-R and prevented apoptosis due to growth factor deprivation5,153. There
appears to be a parallel between integrin-GF-R and integrin-FcεRI interaction.
In both cases fibronectin serves as a “pseudo-ligand” and the integrin as a
“pseudo-ligand binding receptor subunit” of the physically associated receptor
(GF-R or FcεRI). Hence, adhesion triggers the signal transduction cascade of
the latter. Finally, our data show that rafts play a role in VLA-5 mediated
adhesion, possibly due to their enrichment with Src-kinases that are important
for focal adhesion complex formation58. Since these membrane microdomains
have also been shown to be important for FcεRI-signaling144, this suggests a
role for rafts in adhesion-induced degranulation.
Based on these data we propose the following model (figure 1). On the mast
cell membrane VLA-5 and FcεRI are colocalized, and may be physically
associated in small assemblies. On resting mast cells (A), due to a low affinity
conformation of VLA-5, adhesion is absent and these assemblies are randomly
distributed on the mast cell membrane. Lipid rafts are distributed on the
membrane in an identical “patchy” manner and there is no association between
the raft and receptor pools. Conversion of VLA-5 into a high-affinity
conformation by an external stimulus induces binding to fibronectin and leads to
an accumulation of the integrin and FcεRI at the cell-fibronectin interface. (B)
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Figure 1. Adhesion to fibronectin induces the formation of supramolecular activation
clusters in mast cells. A. In resting mast cells, small low-affinity VLA-5-FcεRI assemblies and
rafts are not associated but randomly distributed in a patchy manner on the plasma membrane.
B. Conversion of VLA-5 to a high-affintity conformation induces the accumulation of VLA-5 and
FcεRI at the cell-fibronectin interface. Subsequent association with rafts and focal adhesion
complex (FAC) formation leads to the assembly of  supramolecular activation clusters (SMACs).
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Association with rafts and formed focal adhesion complexes leads to the
assembly of supramolecular activation clusters (SMACs)3,68,114. Interaction
between FcεRI and components of focal adhesion complexes have been
demonstrated previously by others65,86,122 .
The formation of SMACs could account for both adhesion-enhanced and
adhesion-induced degranulation, and both phenomena are discussed below.
First, stabilization of FcεRI aggregates in SMACs could enhance FcεRI
signaling according to the concept of ‘kinetic proofreading’, which states that a
cascade of intracellular events unfold as long as the initiating event is
maintained71,104,159. Secondly, they could affect the activation threshold of FcεRI
(the minimal amount of allergen required for sufficient FcεRI and raft
aggregation in order to trigger degranulation). Adhesion-induced aggregation, or
‘preclustering’, of FcεRI and rafts into SMACs, could lower the activation
threshold and thus increase the sensitivity for allergen stimulation. Overall, we
imagine that degranulation of mast cells depends on the degree of SMAC
assembly (figure 2), and that several processes may contribute to this process
either alone or in combination. In the case of resting IgE-sensitized mast cells,
bearing only VLA-5 in a low-affinity conformation, no SMACs are formed
(situation A). In these cells degranulation can only be triggered by allergen and
these cells therefore have the lowest sensitivity (a high activation threshold).
Increase in the number of high-affinity VLA-5 molecules (situation B) and
subsequent SMAC assembly lowers the FcεRI activation threshold and
adhesion-enhanced degranulation is observed. At a certain degree of SMAC
formation (situation C) the FcεRI activation threshold is reduced to zero. At this
point allergen is no longer required, because by adhesion a sufficient amount of
FcεRI is clustered to trigger degranulation by itself. The latter situation is
probably the case in our experimental setup and explanatory for adhesion-
induced degranulation of BMMC.
Microenvironmental regulation of mast cell function
Our data suggest that the affinity status of VLA-5 determines the sensitivity of
mast cells for allergen. A range of mediators that can be produced by various
cell types can trigger inside-out signaling of integrins. Local variations in the
mast cell microenvironment could thereby regulate mast cell sensitivity and
prime these cells for allergen stimulation. The observation that skin atopy does
not always correlate with allergic disease could be explained by low sensitivity
of mast cells in the body as described in situation 2.A. Organ restriction of
allergy could be due to priming of local mast cells by VLA-5-activating mediators
produced by the mast cell surrounding tissue, as in situation 2.B. At locations of
severe tissue inflammation the concentration of inflammatory, and integrin-
activating, mediators reaches high levels and situation 2.C could occur. In
chapter 6 we show that in addition to Mn2+, Zn2+, Ni2+ and Co2+ are able to
induce VLA-5 mediated adhesion of BMMC to fibronectin and subsequently
trigger adhesion-induced degranulation. These metals are known for their ability
to induce clinical phenomena of allergy, but the mechanism of action is not
completely understood. Our data suggest that divalent cations might induce a
conformational change of VLA-5 on mast cells and induce degranulation due to
situation 2.C and thereby provide a plausible explanation for metal-induced
hypersensitivity responses.
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An additional modulating factor from the mast cell microenvironment is
suggested by data presented in chapter 3. Our data suggest that limited
availability of cholesterol in the mast cell microenvironment could impair the
maintenance of rafts in the mast cell membrane. Subsequently affected raft
integrity could disturb SMAC assembly and thereby affect mast cell sensitivity
for allergen.
Future directions in anti-allergic therapy
Ra et al. and Yasuda et al. have shown that blocking of VLA-5 with specific
antibodies inhibits passive cutaneous anaphylaxis responses in mice131,177.
Blocking of VLA-5 mimics situation 2.A of our model because SMAC assembly
in mast cells is prevented. Decreased mast cell sensitivity and limited allergen
concentrations that reach the location of these mast cells could thereby be
explanatory for abrogation of activation in vivo.
Instead of using antibodies we suggest a different approach to block VLA-5
adhesion based on the experiments described in chapter 5. We show that
calcium-like peptides are able to block adhesion of BMMC to fibronectin. These
peptides probably bind to the cation-binding domains of the VLA-5 α-subunit
that are homologous to calmodulin EF-hands, and thereby interfere with VLA-5
function. Making mast cells less responsive to allergen by blocking VLA-5 could
be a strategy for therapy in allergic responses. The observation that CALPs can
block VLA-5 function suggests that these peptide calcium-mimetics may be
possible lead compounds for anti-allergic drugs.
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β-CD methyl-β-cyclodextrin
BMMC bone marrow-derived mast cells
CALP calcium-like peptide
CaM calmodulin
CFDA 4-(and-5)-carboxyfluorescin diacetate
CTMC connective tissue-type mast cells
DNP dinitrophenyl
FcεRI high-affinity receptor for IgE
FCS fetal calf serum
IL interleukin
ITAM immunoreceptor tyrosine-based activation motif
MIRR multichain immune recognition receptor
MMC mucosal mast cells
MWCO molecular weight cut-off
PAO phenylarsene oxide
PTK protein tyrosine kinase
RGD arginine-glycine-aspartic acid
SCF stem cell factor
SDS sodiumdodecyl sulfate
SH2 Src-homology-2
TBS tris-buffered saline
VLA-5 very late antigen-5
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Iedere dag staan we bloot aan ontelbare schadelijke micro-organismen en
stoffen. Om te overleven is het immuunsysteem constant in actie om deze
factoren in ons lichaam te bestrijden. Als voorbeeld nemen we een bacterie. Na
het lichaam te zijn binnengedrongen, via bijvoorbeeld een huidwond, wordt de
bacterie gesignaleerd door het immuunsysteem wat leidt tot de productie van
antistoffen (figuur 1). Binding van de geproduceerde antistoffen aan de bacterie
zorgt ervoor dat deze herkend kan worden door cellen van het immuunsysteem
die gemoeid zijn met de opruiming
van lichaamsvreemde substanties, de
effectorcellen. Op grond van een
bepaald gedeelte van antistoffen, het
Fc-domein, worden deze onder-
verdeeld in verschillende klassen. De
klasse van de geproduceerde antistof
is bepalend voor het verdere verloop
van de afweerreactie. Voor iedere Fc-
domeinklasse bestaat namelijk een
specifieke Fc-receptor, IgG antistoffen
bijvoorbeeld worden specifiek
gebonden door Fcγ-receptoren. Door-
dat verschillende Fc-receptoren op
verschillende effectorcel-types
voorkomen, bepaald de klasse van
het antilichaam welke effectorceltype
aangewend wordt ter bestrijding van
de indringer.
Sommige lichaamsvreemde stoffen
zoals bijvoorbeeld huisstofmijt,
zogenaamde allergenen, bevatten tot op heden onopgehelderde
eigenschappen die leiden tot de productie van IgE antistoffen. Het
geproduceerde IgE bindt aan de Fc-receptor voor IgE, FcεRI, die zich bevindt
op mestcellen (figuur 2). IgE-productie en –binding aan de mestcel, leidt niet tot
verdere reacties maar bewapent deze cel wel voor een volgend contact met
hetzelfde allergeen, het betreffende individu is nu allergisch1. Bij hernieuwd
contact wordt het allergeen gebonden door het IgE op de mestcel wat leidt tot
activatie van deze cel. De naam “mestcel” werd afgeleid van het Duitse “Mast-
zelle”, wat “weldoorvoede cel” betekent. Hun “volgevreten” uiterlijk danken
mestcellen aan het feit dat ze dat ze vol zitten met blaasjes, granules, gevuld
met ontstekingsmediatoren zoals histamine en serotonine (zie ook hoofdstuk 1
figuur 2). Mestcelactivatie leidt tot het legen van de granules, degranulatie,
waarna de vrijgekomen ontstekingsmediatoren in het omliggende weefsel de
kenmerken van een allergische reactie, zoals jeuk en zwelling, veroorzaken.
In de westerse wereld is het aantal gevallen van allergische aandoeningen,
zoals bijvoorbeeld astma, zo sterk toegenomen gedurende de afgelopen eeuw,
                                                
1 De termen atopie en allergie zijn tegenwoordig bijna synoniem en worden willekeurig
doorelkaar gebruikt. Kenmerken van atopie zijn: verhoogde hoeveelheden allergeen-specifiek
IgE in het bloed en een allergische reactie in een huidtest.
lichaamsvreemd
(antigeen)
activatie
Fc-domein
antigeen-
bindende
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effector-
cel
antigeen
bestrijding
immuun
systeem
Figuur 1. Een afweerreactie tegen een
lichaamsvreemde substantie
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dat vandaag de dag iedereen er wel
direct of indirect mee geconfronteerd
wordt. Onderzoek heeft aangetoond
dat zowel genetische als omge-
vingsfactoren verantwoordelijk zijn
voor het ontstaan van atopie. Deze
onderzoeksresultaten geven echter
geen verklaring voor de observatie
dat bij twee personen die beiden
atopisch zijn voor huisstofmijt, dit
allergeen bij de één astmatische
klachten veroorzaakt en bij de ander
niet. Verder kan een allergeen in de
ene persoon leiden tot een
aandoening in de bovenste, bij een
ander in de onderste luchtwegen en
bij een derde persoon aanleiding
geven tot klachten in meerdere
organen. In al deze voorbeelden zijn
de personen atopisch, dat wil
zeggen, in het lichaam bevinden zich
met “IgE-bewapende” mestcellen,
maar dit hoeft dus niet per se te
leiden tot een allergische reactie.
Deze observatie impliceert dat
factoren uit de naaste omgeving van
de mestcel de activatie van deze cel
kunnen moduleren.
Mestcellen bevinden zich in alle weefsels en organen van het lichaam en zijn
daar omgeven door diverse factoren waaronder de extracellulaire matrix, een
netwerk van eiwitten dat in organen het cement tussen de cellen vormt.
Adhesie, hechting, van mestcellen aan fibronectine, een bestanddeel van de
extracellulaire matrix, vindt plaats via oppervlaktemolecuul VLA-5. Onderzoek
heeft aangetoond dat adhesie van mestcellen aan fibronectine leidt tot
verhoogde degranulatie na allergeen-stimulatie.
De manier waarop adhesie aan fibronectine ervoor zorgt dat de uitstoot van
mestcelmediatoren verhoogd wordt, is onduidelijk. Opheldering hiervan kan
potentiële aangrijpingspunten opleveren voor de ontwikkeling van toekomstige
therapie tegen allergie en is daarom onderwerp van dit proefschrift (figuur 3).
immuun
systeem
allergeen
IgE
FcεRI
mest-
cel
“atopie”
hernieuwd
contact met
allergeen
onstekings-
mediatoren
weefsel
Figuur 2. Een allergische reactie
fibronectine
onstekings-
mediatoren?
VLA-5 VLA-5
Figuur 3. Vraagstelling van dit proefschrift
“Op welke manier moduleert adhesie aan
fibronectine de degranulatie van mestcellen?”
(Ofwel: hoe beinvloedt VLA-5 de functie van
FcεRI?)
FcεRI
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Voor ons onderzoek maakten wij gebruik van mestcellen die gekweekt worden
uit het beenmerg van muizen. Op deze cellen bevindt VLA-5 zich in een vorm
die niet hecht aan fibronectine. Om adhesie te stimuleren werd mangaan aan
deze cellen toegevoegd. Dit metaal bindt aan VLA-5 en zorgt voor een
vormverandering die binding aan fibronectine mogelijk maakt (figuur 4).
Onze resultaten laten twee belangrijke fenomenen zien. Ten eerste verhoogt
adhesie aan fibronectine mestceldegranulatie als gevolg van allergeen-
stimulatie. Ten tweede blijkt dat adhesie aan fibronectine zelf al voldoende om
uitstoot van ontstekingsmediatoren op te wekken, zonder dat daar
allergeenstimulatie voor nodig is.
FcεRI en VLA-5 zijn beide receptoren, eiwitten op het celoppervlak met als
functie een signaal van buiten de cel naar binnen door te geven. Deze
signaaltransductie leidt vervolgens tot een reactie van de cel. Aanwezigheid van
allergeen buiten de cel wordt door FcεRI doorgegeven en leidt tot
mestceldegranulatie. FcεRI-signaaltransductie komt op gang na clustering van
FcεRI door binding aan verschillende bindingsplaatsen op hetzelfde
allergeenpartikel (figuur 5). De sterkte van degranulatie wordt bepaald door een
aantal factoren. Ten eerste is een minimale hoeveelheid allergeen nodig om
voldoende receptoren te clusteren voor mestcelactivatie, dit wordt de
activatiedrempel van de receptor genoemd. Ten tweede leidt een hogere mate
van receptorclustering, bepaald door de hoeveelheid aanwezig allergeen, tot
een sterkere activatie. Ten derde geldt dat de kracht van een individuele
receptor bepaald wordt door de lengte van zijn verblijftijd in het receptorcluster,
ofwel: hoe stabieler een receptorcluster des te sterker de reactie.
fibronectine
VLA-5
+ mangaan:
Figuur 4. In de linker situatie bevindt VLA-5 zich in een vorm die niet bindt aan fibronectine.
Toegevoegd mangaan (rechts) bindt aan VLA-5 zodat deze verandert van vorm en adhesie aan
fibronectine mogelijk wordt.
signaal-
transductie
allergeen
FcεRI
receptorclustering
Figuur 5. In afwezigheid van allergeen is FcεRI random verspreid over het mestceloppervlak.
IgE-binding aan allergeen veroorzaakt clustering van FcεRI. Deze clustering geldt als signaal
voor de mestcel om over te gaan tot degranulatie.
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Onze resultaten laten zien dat VLA-5 en FcεRI zich op het mestceloppervlak in
elkaars nabijheid bevinden, en misschien zelfs wel verbonden zijn. Dat houdt in
dat wanneer VLA-5 geclusterd wordt door adhesie aan fibronectine, FcεRI
meeverhuist naar het VLA-5 cluster en daardoor ook geclusterd wordt (figuur 6).
Door deze “pre”-clustering wordt de activatiedrempel van FcεRI verlaagd en
wordt de mestcel gevoeliger voor allergeen. Een aan fibronectine gehechte
mestcel zal sterker reageren op een bepaalde hoeveelheid allergeen dan een
niet gehechte mestcel doordat FcεRI-clustering veroorzaakt door allergeen en
die door adhesie optelbaar zijn.
Bij eenzelfde hoeveelheid allergeen, leidt in gehechte mestcellen een grotere
hoeveelheid geclusterd FcεRI tot verhoogde degranulatie. Verder zorgt de pre-
clustering van FcεRI in het VLA-5 cluster voor verhoogde stabiliteit en daardoor
sterkere reactie. Bij een bepaalde mate van VLA-5-adhesie is de preclustering
van FcεRI dermate dat de activatiedrempel van deze receptor spontaan
overschreden wordt en er degranulatie optreedt zonder dat daar allergeen voor
nodig is. De observatie dat mestcellen ontstekingsmediatoren uitscheiden door
clustering van VLA-5, zou verklarend kunnen zijn voor het ontstaan van
metaalallergieën, waarvan de manier van ontstaan grotendeels onduidelijk is.
Van mangaan, kobalt, nikkel en zink is bekend dat ze een allergische reaktie
teweeg kunnen brengen. In onze experimenten vonden wij al deze metalen in
staat zijn mestcel adhesie aan fibronectine te veroorzaken. Deze adhesie leidde
vervolgens tot degranulatie.
Zoals hierboven reeds beschreven, bevindt VLA-5 zich op rustende mestcellen
in een vorm die niet bindt aan fibronectine. In deze cellen is FcεRI dus niet
gepreclusterd en deze cellen zijn dus relatief ongevoelig voor
allergeenstimulatie. Verandering van VLA-5 naar een vorm die fibro-
fibronectine
fibronectine
fibronectine
VLA-5 in de vorm die geen fibronectine bindt
FcεRI
VLA-5 in de vorm die wel fibronectine bindt
Figuur 6. Op het mestceloppervlak bevinden
VLA-5 en FcεRI zich in elkaars nabijheid. Op
rustende mestcellen (boven) is VLA-5
aanwezig in een vorm die niet bindt aan
fibronectine. In deze situatie is FcεRI niet
gepreclusterd en de mestcel is dan het minst
gevoelig voor allergeen-stimulatie. Door
omgevingsfactoren (weefsel, metalen etc.)
verandert de vorm van VLA-5 (midden).
Vervolgens wordt fibronectine gebonden en
FcεRI gepreclusterd. De mestcel wordt
gevoeliger voor allergeen en degranulatie
door allergeenstimulatie is sterker. Bij zeer
sterke hechting aan fibronectine (onder)
wordt zoveel FcεRI geclustered, dat aller-
geen niet meer nodig voor overschrijding van
de activatiedrempel. Adhesie veroorzaakt nu
rechtstreeks degranulatie.
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nectinebinding mogelijk maakt kan, behalve door de hierboven beschreven
metalen, worden geïnduceerd door verscheidene stoffen die plaatselijk in het
weefsel aangemaakt worden. De gevoeligheid van de mestcel, correlerend met
de vorm van VLA-5 en hechting aan fibronectine, kan dus per locatie in het
lichaam gemoduleerd worden door gereguleerde aanmaak van deze stoffen.
Samenvattend kan geconcludeerd worden dat het al dan niet optreden van een
allergische respons in een weefsel in een atopische situatie afhangt van de
gevoeligheid van de mestcellen ter plaatse. Het uitblijven van een allergische
reactie zou in dit geval verklaard kunnen worden door te zeggen dat de
hoeveelheid allergeen ter plaatse te laag is om de activatiedrempel van FcεRI
te overschrijden.
Door adhesie aan fibronectine te blokkeren, zou een mestcel dus in een relatief
minder gevoelige staat gehouden kunnen worden, waardoor een allergische
reactie minder snel optreedt. Blokkering van VLA-5 functie biedt volgens het
hierboven beschreven model mogelijkheden als toekomstige therapie tegen
allergische aandoeningen en verdient daarom nadere bestudering.
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